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Background: Methamphetamine (MA) abuse is a growing problem in the world and 
especially in South Africa’s Western Cape.  Amphetamine-type stimulants have become 
the second most widely abused illicit drugs worldwide. Admission data from substance 
abuse treatment centres in the Western Cape show the fastest increase for any drug ever 
noted in the country in MA related admissions. MA has neurotoxic effects on the brain 
leading, amongst other effects, to white matter (WM) changes. Moreover, increased 
levels of aggression are commonly found in individuals with MA abuse. Although 
behavioural deficits are well described, the underlying mechanisms are still poorly 
understood. While previous studies have examined WM abnormalities relating to 
cognitive impairment, none have investigated associations between WM integrity in 
individuals with MA dependence and aggression. 
 
Methods: Diffusion Tensor Imaging (DTI) was used to investigate WM changes in 40 
individuals with MA dependence and 40 matched healthy control subjects. Aggression 
was measured with the Buss & Perry Questionnaire in 40 MA users and 36 controls. Two 
approaches to assess WM integrity in the brain were employed. First, whole brain voxel 
wise comparison across subjects using tract based spatial statistics (TBSS) in FSL was used. 
Fractional anisotropy (FA), mean diffusivity (MD), parallel diffusivity (λ║) and 
perpendicular diffusivity (λ┴) were compared between the two groups. Second, a region 
of interest (ROI) approach was used, which focused on three WM tracts in the frontal 
brain, commonly found to play a role in aggressive behaviour: (1) the genu of the corpus 
callosum (CC), (2) the cingulum and (3) the uncinate fasciculus. 
 
Results:  Mean aggression scores for Anger (p<0.001), Physical Aggression (p=0.032) and 
Total scores (p=0.021) were significantly higher in the MA group then in the controls. TBSS 
analysis revealed increased MD values in the right superior corona radiata in the MA 
group. ROI analysis showed increased MD (U= 439,5, p=0.00) and λ┴ (U=561,5, p=0.021) 
values in the genu of the CC in individuals with MA dependence. MD (U=541,5, p=0.012) 
values were also increased in the MA group in the right hippocampal region of the 
cingulum. There were no group differences in the uncinate fasciculus. None of the WM 




Conclusion: This study provides evidence of WM differences between abstinent 
individuals with MA dependence and healthy controls. Moreover, higher aggression levels 
in the MA group were found. The lack of significant association between WM changes and 
aggressive behaviour may reflect methodological issues in measuring such behaviour, or 
may indicate that the neurobiology of aggression is not simply correlated with WM 
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Worldwide, methamphetamine (MA) abuse has accelerated dramatically. As a result of its 
easy and inexpensive production, amphetamine-type stimulants (ATS) have become the 
second most widely abused illicit drug worldwide (United Nations Office on Drugs and Crime 
[UNODC], 2012). The newly released World Drug Report (UNODC, 2014) stated that globally 
a total of 144 tons of ATS were seized in 2012.  
 
MA abuse in South Africa’s Western Cape has also shown an enormous increase in the last 
decade. Worldwide, South Africa ranks on place three of ATS prevalence. Furthermore, the 
UNODC reports an increase in MA and heroin abuse in South Africa with other drugs being 
stable in 2012. Simbayi et al. (2006) showed that 18% of men and 12% of women in a 
township in Cape Town admitted having tried MA at least once. MA was also reported the 
second most abused drug (after cannabis) among treatment patients in Cape Town younger 
than 20 years (Plüddemann et al., 2010). Admission data from substance abuse treatment 
centres in in that area during a four-year period (2002–2006) state the proportion of patients 
reporting MA as their primary substance of abuse show a steady increase from 0.3% to 
42.3%. This represents the fastest increase in admissions for any particular drug ever noted 
in the country (Plüddemann, Myers & Parry, 2008) with numbers declining only minimally to 
35 % in 2008  (Plüddemann et al., 2013).  
 
MA is a highly addictive synthetic psychostimulant, which can cause serious general and 
mental health problems, including psychosis, depression, cognitive impairment, anxiety and 
violent behaviour (Cherner et al., 2010; Darke et al., 2008; McKetin et al., 2008). MA, also 
known by its street name ‘tik’, is commonly smoked in a glass pipe or similar device but can 
also be injected, swallowed or sniffed. Immediate effects include euphoria, confidence, 
physical activity, decreased appetite, arousal and sleeplessness (Darke et al., 2008; Panenka 
et al., 2013; Romanelli & Smith, 2006).  
 
Drug abuse is a massive burden for society. The United States spent estimated 193 billion 
US$ in 2007 for health and legal costs, loss of productivity, incarcerations and other 
consequences of illegal drug use (National Drug Intelligence Centre, 2011). Furthermore, for 
communities MA abuse is a social burden. Several studies report on the social impact on 




(Plüddemann, Louw & Leggett, 2004; Sommers & Baskin, 2006; Watanabe-Galloway et al., 
2009). Additionally, Haight et al. (2010) showed that children growing up in families involved 
in MA abuse are at a higher risk to develop aggressive behaviour, depression, and mental 
health problems. Individuals with MA abuse also engage more likely in risky sexual behaviour 
leading to sexually transmitted infections like HIV (Plüddemann et al., 2013). Taken together, 
MA abuse has a negative impact on several levels, the personal, the communal, and the state 
level.  
 
One of the serious consequences of MA use, I am going to concentrate on in this work, is the 
increased levels of aggression in individuals with MA dependence. It is widely reported that 
individuals with MA dependence show more aggressive behaviour (Boles & Miotto, 2003; 
Booth et al., 2006; Cohen et al., 2003; Lapworth et al., 2009; Payer et al., 2011; Plüddemann 
et al., 2010; Sommers & Baskin, 2006; Zweben et al., 2004) leading to domestic abuse, 
increased crime rates and corruption (Watt et al., 2014). 80% of women enrolled in a MA 
treatment program reported domestic violence from their partner and 57.6% stated that 
they have been sexually abused (Cohen et al., 2003). Cartier, Farabee and Prendergast (2005) 
reported, “methamphetamine use was significantly predictive of self-reported violent 
criminal behaviour and general recidivism”. Additionally, Plüddemann et al. (2010) showed 
in a study with 1561 high school students in Cape Town that MA abuse was significantly 
related to higher aggressive behaviour.  
 
The second effect of MA dependence, that I am going to investigate in this thesis, is the 
neurotoxicity of the drug, leading to neuronal cell damage and subsequently to structural 
changes in the brain (Cadet & Krasnova, 2009; Davidson et al., 2001; Riddle et al., 2006). 
These changes at the cell level result in changes of fibre connections in neural circuits. Recent 
imaging studies have described several white matter (WM) changes in MA abuse as well as 
their association with problems in cognitive control (Alicata et al., 2009; Chung et al, 2007; 
Kim et al., 2009) and psychiatric disorders (Tobias et al., 2010). Diffusion tensor imaging (DTI) 
is an optimal tool for investigating WM changes because it can measure WM integrity in-vivo 
based on the diffusion of water molecules. There are only a limited number of DTI studies in 
MA abuse though. Previous studies showed impaired WM integrity in aggressive and 
impulsive behaviour, psychiatric disorders, which show increased levels of aggression and in 




et al., 2014). However, the relationship between WM changes in MA abuse and behavioural 
deficits are still unclear.  
 
Based on this background the rationale of this study was to delineate the relationship 
between WM changes and aggression in individuals with MA dependence.  Therefore, DTI 
data from participants of an ongoing MA imaging study at the University of Cape Town were 
analysed and correlated with the scores from a self-report Aggression Questionnaire (Buss & 
Perry, 1992).  
The thesis will comprise four further chapters, as follows: 
The first chapter contains a literature review, where I will explain DTI, which was used in this 
study to delineate the WM changes in MA dependence. I will then summarize studies 
conducted in MA abuse concentrating on the neurobiological effects of MA consumption as 
well as neuroanatomical regions involved as shown by several neuroimaging studies. In the 
last section, I will focus on aggression, reviewing what is known about the neurobiology and 
the neural correlates of aggressive behaviour. Ending this chapter, I will discuss my 
hypothesis and objectives. 
 
The second chapter contains an introduction to DTI analysis using the functional MRI analysis 
programs of the Brain Software Library (FSL). There, I will explain the recruitment process 
and questionnaires used in this research. I will also highlight the statistical procedures for 
analysing the results.  
 
A third chapter will state the results of this research. The fourth chapter summarizes these 
results and places them back into the context of WM differences in MA dependence and its 
relevance for behavioural changes. I will also suggest ways in which research can be 
continued to build even further upon our understanding of how WM changes relate to 











1. Literature Review 
1.1 Diffusion Tensor Imaging 
WM fibre pathways connect cerebral cortical areas with each other and with subcortical 
structures. Thereby, they allow communication between different brain regions building the 
neural network that subserves sensorimotor function, intellect and emotion. Abnormalities 
in WM have been associated with a wide spectrum of emotional disturbances (Filley, 1998), 
cognitive impairment (Alicata et al., 2009; Chung et al., 2007; Kim et al., 2009) and psychiatric 
disorders (Saxena et al., 2012; Sundram et al., 2012; Tobias et al., 2010; Zhang et al., 2014). 
In this section, it will be explained how diffusion tensor imaging (DTI) can be used to 
investigate microstructural WM changes.  
 
DTI is a sensitive brain imaging technique, which relies on the anatomical structure of WM in 
the brain. Cerebral WM consists of axons coated with myelin and covers 40-50% of the adult 
human brain (Filley, 2005). The fibre pathways create a grid with axons going in mainly three 
directions and almost crossing at right angles (Wedeen et al., 2012). DTI provides the 
possibility of following and investigating these fibre pathways non-invasively and enables us 
to examine the anatomical connectivity of the brain.   
 
DTI is an optimal tool for investigating microstructural WM changes in-vivo. It is based on the 
Brownian motion effect of water. In isotropic conditions, like in cerebrospinal fluid (CSF) or 
grey matter (GM), water molecules diffuse randomly in any direction. In a nerve fibre, 
however, the axonal membrane and the myelin sheet restrict movement, resulting in a main 
movement direction along the nerve fibre instead of perpendicular to it (Basser et al., 1994; 
Beaulieu, 2002). The diffusion of water is measured in multiple directions to calculate the 
three mean movement directions resulting in a 3D image. The intensity of each image 
element (=voxel) reflects the water diffusion rate (Mori & Zhang, 2006). If we think of each 
voxel as an ellipsoid shape each axis of the ellipsoid will represent a direction of diffusion 
characterized by the eigenvectors and the radius by the eigenvalues λ1, λ2 and λ3 (Taylor et al. 
2004). In anisotropic tissue the main direction of water diffusion is represented by the largest 
diffusion value λ1, describing the parallel diffusivity (λ║) along the nerve fibre. λ2 and λ3 can 
be used to calculate the restricted perpendicular diffusivity (λ ┴) of water molecules by taking 
the mean of the two values (λ ┴= (λ2 + λ3)/2). Altered microstructure of WM fibre tracts due 
to pathology or physiological changes, influence the magnitudes of the eigenvalues 





From the three diffusivities, we can calculate the fractional anisotropy (FA), which is a 
measure of the restricted movement of water molecules in a nerve fibre. FA is calculated as 
the normalized standard deviation of λ1, λ2 and λ3 in every voxel. Previously reported 
decreases in FA were interpreted as damages to the myelin sheet, the axonal fibre, as 
oedema, or inflammation (Cercignani et al., 2001). FA can therefore be used to describe WM 
integrity (Hasan, Alexander & Narayana, 2004; Le Bihan et al., 2001) and is the most widely 
used measure in DTI brain research (Assaf & Pasternak, 2008). FA values can be between one 
and zero, being high (1) in WM and low (0) in GM and CSF where there is no main directional 
diffusion.  
 
Another measurement used to describe WM changes includes the mean diffusivity (MD) 
which is a direction independent measure of overall diffusion of water molecules in each 
voxel. MD - sometimes called the averaging diffusion coefficient (= ADC) - is calculated as the 
average of the three eigenvalues (MD= (λ1+ λ2 + λ3)/3) (White, Nelson and Lim, 2008). I use 
MD instead of the term ADC because it can easily be confused with the apparent diffusion 
coefficient. Increases in MD might be due to a decrease in membrane density and therefore 




















MA is a white, crystalline, odourless powder, which, in South Africa, is commonly smoked in 
a glass pipe. MA abuse states a serious problem for general health as it can cause extreme 
weight loss, dental problems, insomnia, or high blood pressure increasing the risk for strokes 
(Darke et al., 2008; Panenka et al., 2013; Romanelli & Smith, 2006; Yen et al., 1994). Mental 
health problems include anxiety, paranoia, cognitive impairment, depression, and aggressive 
behaviour (Boles & Miotto, 2003; Booth et al., 2006, Cherner et al., 2010; Darke et al., 2008; 
McKetin et al., 2008). Additionally, MA can cause neural cell damage leading to structural 
changes in the brain. How the cell injuries occur will be covered in the next section.   
 
Neurobiology of methamphetamine  
A recent review by Halpin, Collins & Yamamoto (2014) summarizes the neurotoxic effects of 
MA. Acute MA administration increases extracellular dopamine (DA) and serotonin (5-HT) 
levels. DA levels increase through release of DA vesicles into the synaptic junction and by 
blocking presynaptic dopamine transporters (DAT). This inhibits the reuptake of DA from the 
presynaptic nerve resulting in higher DA concentrations in the synaptic junction. In addition, 
glutamate increase in the striatum was detected (Mark et al., 2004) causing rises in 
intracellular calcium levels which activates calcium-dependent proteolytic enzymes, free 
radicals and nitrite oxide resulting in cell damage and apoptosis (Nicholls, 2004). Chronic use 
of MA however is followed by a depletion of DA and 5-HT by axonal degeneration and axon 
terminal damage due to chronic oxidative stress, direct toxicity of MA and down-regulation 
of receptors (Cadet et al., 2007).  
 
Long-term effects, such as DA and 5HT axon terminal damage, were reported to last over two 
years (Volkow, 2001), specifically in the striatum, hippocampus and the prefrontal cortex 
(PFC) (Seiden et al., 1988; Wagner et al., 1980). Neuronal cell death in the striatum and PFC 
was mainly ascribed to GABA interneurons via mitochondrial and DNA damage as well as 
endoplasmic reticulum stress (Cadet, Jayanthi & Deng, 2005; Kuczenski et al., 2007).  
Other mechanisms contributing to neuronal cell death include oxidative stress, altered cell 
metabolism and inflammation (Quate et al., 2004; Sprague, Everman & Nichols, 1998; 
Thomas et al., 2004). Mechanisms of the latter are not well understood, but thought to be 
activated through microglial activation in striatum, cortex and hippocampus (Kuhn, 




several persistent mechanisms interact with each other and contribute to MA induced cell 
and axon damage.   
 
Dopamine, the reward system and addiction 
Addiction is a state of compulsive drug use despite serious negative consequences (Cami & 
Farré, 2003). In the DSM-IV as well as in our study, criteria for drug dependence are as follows 
(American Psychiatric Association, 2000):   
a. Tolerance (marked increase in amount; marked decrease in effect); 
b. Characteristic withdrawal symptoms; substance taken to relieve withdrawal; 
c. Substance taken in larger amount and for longer period than intended; 
d. Persistent desire or repeated unsuccessful attempt to quit; 
e. Much time/activity to obtain, use, recover; 
f. Important social, occupational, or recreational activities given up or reduced; 
g. Use continues despite knowledge of adverse consequences  
Dependence is diagnosed when three or more criteria are met in a 12-month period. Criteria 
for MA abuse on the other hand are fulfilled when one of the following criteria is met in a 12-
month period (American Psychiatric Association, 2000): 
a. Recurrent use resulting in failure to fulfil major role obligation at work, home or 
school 
b. Recurrent use in physically hazardous situations 
c. Recurrent substance related legal problems 
d. Continued use despite persistent or recurrent social oar interpersonal problems 
caused or exacerbated by substance 
Considerable research has been done and a series of theories about the brain circuits and 
neurotransmitter involved in drug addiction have been proposed. It is clear that DA is not the 
only neurotransmitter playing a role but most certainly it is a pivotal one. Researchers agree 
that DA is not just the ‘reward’ hormone but that it provides things with ‘importance’ or 
‘salience’. In animal studies, it was shown that primates could still “like” a substance in the 
absence of DA but that they would not change their behaviour to obtain such a substance 
(Hyman, Malenka & Nestler, 2003). Berridge & Robinson (1995) stress the difference 




intake causes sensitization to neural areas associated with ‘wanting’ but not ‘liking’. 
Therefore, they conclude that addiction leads to a dissociation of ‘wanting’ and ‘liking’ – 
‘wanting’ becoming more and more prominent while ‘liking’ is declining.  
 
Structural parts of the brain involved in drug addiction are, amongst others, the ventral 
tegmental area (VTA), the nucleus accumbens (NcA), the PFC and the amygdala (Everitt et 
al., 2008; Goldstein & Volkow, 2002). The enjoyable effects of MA are assumed to be caused 
by an increase of DA in the NcA (Keleta & Martinez, 2012; Piazza & Deroche-Gamonet, 2013) 
– the same as for many other drugs of abuse, or natural rewards like food intake or sexual 
behaviour (Everitt, Dickinsen & Robins, 2001). The drug therefore reinforces the natural 
reward system in the brain (Piazza & Deroche-Gamonet, 2013).  
DA neurons in the ventral tegmental area (VTA) project to the NcA (=ventral Striatum) as well 
as the amygdala and hippocampus, building the mesolimbic pathway which plays a role in 
drug-related memories and conditioned responses as well as reward (Koob & Bloom, 1988). 
The mesocortical pathway is made by neurons connecting the VTA to the PFC. The NcA can 
be divided into a core and a shell region. The shell has strong connections to emotion 
regulating areas and responds to novel rewarding stimuli. The PFC, especially the anterior 
cingulate cortex and the orbitofrontal cortex (OFC), are involved in valuating reward and 
inhibitory control over behaviour (Hyman, Malenka & Nestler, 2003).   
 
The transition from drug use to addiction might be regulated by reward-related learning 
processes (Hyman, Malenka & Nestler, 2003). This theory is supported by the experience that 
the drug is continuously taken even if the pleasurable effect is long gone (Volkow, Fowler & 
Wang, 2004). Long-term potentiation (LTP) and long-term depression (LTP) play an important 
role in learning and memory processes. LTP and LTD lead via neuroplasticity to either a 
strengthening or a reduction of synaptic connections, and hence, translate into potentially 
long-term neuronal changes. These changes have been demonstrated to occur in reward 
related brain areas as a consequence of drug use (Hyman, Malenka & Nestler, 2003; Nestler, 
2001). Furthermore, DA enhances LTP in hippocampal-prefrontal cortical synapses (Gurden, 
Takita & Jay, 2000) and therefore strengthens learning processes related to the drug.   
  
As a consequence of these learning-processes changes in neural circuits can be observed. 
Volkow, Fowler & Wang (2004) focus in their review on imaging studies in individuals with 




such as “reward/saliency, motivation/drive, inhibitory control/disinhibition, and 
memory/conditioning”. The authors point out reduced DA activity in drug abuse in the PFC, 
especially in the OFC and the anterior cingulate gyrus, in positron emissions tomography 
(PET) studies. Impaired control of the PFC over behaviour could contribute to the 
uncontrolled, disinhibited drug use seen in individuals with drug abuse (Volkow et al., 2002). 
 
Summarizing the neurobiological effects of MA on the brain and its relevance for addiction, 
acute MA administration leads to an increase of DA levels, but chronic use results in a 
depletion of DA. Additionally, DA plays an important role in the brain reward system, which 
is strongly linked to addiction. MA causes cell damage through multiple mechanisms leading 
to structural changes in the brain. These changes at the cell level may result in changes in 
neural circuits and therefore changes in behaviour.  
 
Neuroimaging in methamphetamine abuse 
Neuroimaging allows researchers to investigate the brain in vivo. Different imaging 
techniques like magnetic resonance imaging (MRI) and spectroscopy (MRS), PET and 
functional MRI (fMRI), have been used to identify structural brain changes in chronic MA 
abuse and dependence but just a limited number used DTI to examine WM integrity. In this 
section, I summarize the results of multiple brain imaging studies investigating the effects of 
MA on the brain. First, I will give an overview of the results of structural MRI studies in MA 
abuse. Then I will focus in more detail on the results of DTI studies in MA dependence.  
 
Methamphetamine and MRI  
A substantial number of studies focused on GM volume changes in MA abuse and 
dependence. The frontal lobe is repeatedly found to exhibit lower GM volumes in individuals 
with MA abuse (Kim et al., 2006; Nakama et al., 2011; Schwartz et al., 2010) as well as in 
users of other ATS’s (amphetamine and 3,4-methylenedioxymethamphetamine (MDMA)) 
(Daumann et al., 2011), compared to healthy controls. Additional findings are lower GM 
density or smaller GM volume in MA abuse in the insula (Nakama et al., 2011; Schwartz et al. 
2010), the parietal lobe (Jernigan et al. 2005), cingulate gyrus, paralimbic and limbic cortices, 
and the hippocampus (Thompson et al., 2004) as well as in the temporal lobe in ATS abusing 
individuals (Bartzokis et al., 2000). Another consistent finding is higher GM volume in the 
striatum in MA abuse (Chang et al., 2005; Jernigan et al., 2005) and other stimulant-abusing 





In addition, WM structural changes have been observed in MA dependence. Thompson et al. 
(2004) found increases in total WM volume, especially in temporal areas surrounding the 
hippocampus and occipital areas, in 22 individuals with a history of MA dependence. Bae et 
al. (2006) found frontal lobe and periventricular WM hyperintensities, which were more 
prominent in male then in female individuals with MA dependence. These findings were 
replicated by Alaee et al. (2014) who similarly found frontal lobe WM hyperintensities in 
individuals with MA dependence. 
 
A study by Mackey et al. (2014) in 165 occasionally ATS using college students found that 
even occasional use of ATS can change brain structure. They showed higher grey matter (GM) 
volume in the left anterior ventral putamen and lower GM volume in the right dorsolateral 
cerebellum and right inferior parietal cortex in the ATS using students. Moreover, the authors 
could show a correlation between mid-insula and ventromedial PFC volumes and lifetime 
amount of ATS use. These findings show that occasional ATS use may already lead to brain 
changes, although they differ from findings in chronic drug use as discussed below.  
 
The pathophysiology of brain volume decrease or increases in GM and WM is still unclear. 
Volume loss might be due to shrinkage of large neurons as seen in the aging brain (Terry, 
DeTeresa & Hansen, 1987). As outlined above, the neurotoxic effects of MA are well studied 
and cell damage and cell death may be due to dopaminergic and serotonergic neurotoxicity 
and synaptic damages. Inflammation on the other hand can trigger reactive gliosis and might 
be the cause for volume increases seen in WM regions (Schwartz et al., 2010; Sekine et al., 
2008; Thomas et al., 2004).  
 
DTI and methamphetamine dependence 
There is only a small body of literature on WM changes in individuals with MA dependence, 
using DTI. Recent studies have described several WM changes in MA dependence as well as 
their association with problems in cognitive control (Alicata et al., 2009; Chung et al., 2007; 
Kim et al., 2009).  
 
The first study published on DTI in individuals with MA dependence was undertaken by Chung 
et al. (2007). The study investigated the relationship of decreased frontal WM integrity and 




dependence had significantly lower FA values in bilateral frontal WM at the anterior 
commissure–posterior commissure (AC–PC) plane, relative to the control group. Executive 
functioning was measured with the Wisconsin card-sorting test (WCST) showing that 
individuals with MA dependence had more total, perseveration and non-perseveration errors 
relative to healthy comparison subjects. Correlational analyses found a relationship between 
decreased FA values of frontal WM and decreased WCST performances in individuals with 
MA dependence.  
 
Subsequently, Kim et al. (2009) measured FA and eigenvalues in the corpus callosum (CC) and 
likewise, correlated their findings to the WCST. They found significantly reduced FA in the 
genu but not in the splenium of the CC in individuals with MA dependence compared to 
controls. The total WCST error score correlated negatively with FA and positively with the 
perpendicular diffusion coefficient (λ┴), but not with the parallel diffusion coefficient (λ║). 
Both of these studies support the idea that decreased frontal WM integrity may underlie 
poor frontal executive function observed in individuals with MA dependence. 
 
Another task examining cognitive control, the Stroop selective attention task, was used in a 
study by Salo et al. (2009) to study the relationship between behavioural regulation and WM 
microstructure within the callosal region. They measured FA, ADC (=MD) and eigenvalues in 
the splenium and genu of the CC.  The authors showed greater Stroop reaction time 
interference in individuals with MA dependence compared with healthy controls. In addition, 
FA within the genu but not splenium correlated significantly with measures of cognitive 
control in individuals with MA dependence but not in controls. However, their FA values in 
the genu of the CC did not survive correction for multiple comparisons.  
 
Alicata et al. (2009) also showed lower FA in right frontal WM and additionally, higher ADC 
in the left caudate and bilateral putamen in individuals with MA dependence compared to 
controls. Using the Addiction Severity Index (ASI) they describe a link between drug 
measurements, like “earlier initiation of MA use, greater daily amounts, and a higher 
cumulative lifetime dose”, and increased ADC values in the left putamen. ADC in the right 
putamen was also associated with greater daily MA amounts and a higher cumulative lifetime 
MA dose. As previously discussed (Alexander et al., 2007) higher ADC can be interpreted as 
increased water content in each voxel as occurring in inflammation, or damage to the myelin 




to more damage in this region, associated with younger age of first MA use and greater MA 
usage.  
 
Tobias et al. (2010) investigated the relationship of WM abnormalities with mood and 
psychiatric symptoms. They used the Beck Depression Index (BDI) score as a measure of 
depressive symptoms and the Brief Symptom Inventory (BSI) Positive Symptom Total score 
as a global measure of psychiatric symptoms. FA was measured at eight regions in the CC and 
at four inferior-superior levels parallel to the AC–PC plane (AC= anterior commissure, PC= 
posterior commissure). Their findings included lower FA in right prefrontal WM above the 
AC–PC plane, in the genu corpus of the CC, right midcaudal superior corona radiata and in 
right perforant fibres in MA dependence compared to controls. Decreased FA in left 
midcaudal superior corona radiata was correlated with BDI and BSI scores within the MA 
group. 
 
In conclusion, several DTI measures indicating impaired WM integrity have been shown to 
correlate with diminished frontal executive function (Chung et al., 2007; Kim et al., 2009; Salo 
et al., 2009), addiction severity (Alicata et al., 2009) as well as depressive symptoms and 
generalized psychiatric dysfunction (Tobias et al., 2010) in MA dependence. Damage to the 
frontal WM and the genu of the CC in particular may underlie the cognitive and behavioural 



















MA abuse has been strongly linked to aggressive behaviour (Boles & Miotto, 2003; Booth et 
al., 2006; Cartier, Farabee & Prendergast, 2005; Cohen et al., 2003; Payer et al., 2011). 
Aggression – as defined by Buss (1961)-is a “response that delivers noxious stimuli to another 
organism”. Geen (2001) gives a more extensive explanation:  “Aggression is the delivery of 
an aversive stimulus from one person to another, with intent to harm and with an 
expectation of causing such harm, when the other person is motivated to escape or avoid 
the stimulus”. In my thesis, I will use the term aggression as most psychologists define it - 
simply as an act intended to harm others (Baron & Richardson 1994; Anderson & Bushman, 
2002). 
 
After presenting different forms of aggression, I will depict the relationship between MA and 
aggression and illustrate why it is important to investigate the possible mechanisms of 
aggressive behaviour in MA abuse. To explain the underlying neurobiology of aggression, I 
will then return to the discussion about the role of DA and 5-HT in the brain and describe 
how MA influences their concentration levels. Concentrating on the structural brain changes 
that are linked to aggressive behaviour, I will then emphasize that MA causes damage in 
similar regions important for emotion regulation particularly in the PFC, the CC and parts of 
the limbic system.  
 
Forms of aggression 
There are many ways to distinguish forms of aggression. A widely accepted form and the one 
I am going to focus on in my thesis is the differentiation between reactive and instrumental 
aggression. Instrumental aggression, also referred to as proactive or premeditated 
aggression, is a goal-related, offensive form of aggression. The drive for this form of 
aggression is the reward the perpetrator receives after the planned aggressive act (Vitaro, 
Brendgen & Baker, 2006). Alternatively, as Barret & Felthouse (2003) explain it: the “assault 
[is] carried out to benefit the attacker in some way”.  
 
Reactive aggression on the other side, also known as the affective/emotional form, is usually 
triggered by a threat or frustration (Tuvblad et al., 2009). It is immediate (impulsive) and 
unplanned and goes mostly hand in hand with an expression of anger. Impulsivity is closely 




unplanned reactions to internal or external stimuli without regard to the negative 
consequences of these reactions to themselves or others’’ (Moeller et al., 2001).  
 
Barret & Felthouse (2003) state that impulsivity is a risk factor for reactive aggression. 
Individuals with MA abuse tend to have decreased behavioural inhibition (Kim et al., 2005; 
Davidson et al., 2001; Lapworth et al., 2009). Lapworth et al. (2009) found a link between 
impulsivity and hostility in MA users. They showed that impulsivity has a moderating role in 
the relationship of MA use and hostility. Increased dependence on MA correlated with higher 
levels of impulsivity and was associated with increased hostility. Consecutively, Schwartz et 
al. (2010) found higher impulsivity scores in MA users then in control.  
Therefore, the major form of aggression in MA abuse suggests to be reactive aggression 
rather than instrumental.  
 
Methamphetamine and aggression 
Previous animal studies on the effects of MA on aggressive behaviour first showed mixed 
results. On the one hand, Crowley et al. (1972) noticed more fighting in MA administered 
mice, but others did not (Miczek and O’Donell, 1978). An animal study by Sokolov, Schindler 
& Cadet (2004) showed that chronic MA administration to mice is associated with more 
aggressive and hostile behaviour but not in single exposure with MA.  
 
Numerous human studies show increased aggressive behaviour in individuals with MA abuse 
and dependence (Lapworth et al., 2009; Payer et al., 2011; Plüddemann et al., 2010; 
Sommers & Baskin, 2006; Zweben et al., 2004). Plüddemann et al. (2010) found in a study 
with 1561 high school students from Cape Town that “methamphetamine use in the past 
year was significantly associated with higher aggressive behaviour scores”. Only a few studies 
list the causes of violent behaviour as Sexton et al. (2009) do: “disputes over MA or its use, 
as well as paranoia, ill-tempers, and hallucinations during MA binges”. This emphasises how 
important it is to understand the mechanisms underlying aggressive behaviour in MA abuse.  
 
Nevertheless, the precise nature of the relationship between MA abuse and aggression is still 
unclear. Payer, Liebermann and London (2011) questioned if MA abuse might not be the 
cause but the result of aggressive behaviour and impulsivity. Sommers, Baskin & Baskin-
Sommers (2006) on the other hand found that half of all individuals with MA abuse who 




also possible that pre-existing aggressive and impulsive personality traits exacerbate by the 
use of MA. Another theory by Dawe et al. (2009) is that MA use is not the direct cause of 
making subjects aggressive, but for example, that other factors such as the sleep deprivation 
caused by the psychostimulant are more relevant. Another widely discussed hypothesis is 
that positive psychotic symptoms, particularly paranoia and suspiciousness, precipitated by 
the use of MA, can stimulate aggressive behaviour (Lapworth et al., 2009). Clearly, a 
seemingly hostile environment would trigger aggression as well. Lapworth et al. (2009) found 
that patients who had severe positive psychotic symptoms and high impulsivity were the 
most hostile.   
 
Studies have shown that individuals with MA dependence have difficulties recognizing angry 
faces. Facial expressions are a social cue to change behaviour in dangerous situations (Payer 
et al., 2007). Hoptman (2003) argues that individuals with deficiencies in fear processing (not 
being able to process social fearful stimuli like angry faces) may be unable to avoid dangerous 
situations or withdraw themselves of such. The amygdala plays a key role in recognizing facial 
expressions and in fear processing (Costafreda et al., 2008; Davis, 1997; Hoptman, 2003; 
Sergerie et al., 2008). The inferior PFC has strong connections to the amygdala and modulates 
its activation (Davidson, Putnam & Larson, 2000; Peters & Sethares, 2002). Hoptman (2003) 
concludes that abnormalities in the inferior frontal cortex might change its modulatory role 
over the amygdala and result in impaired fear processing. Likewise, Davidson, Putnam & 
Larson (2000) state that lesions in the OFC as part of the PFC produce syndromes 
characterized by impulsivity and aggression.  
 
Applying these findings to the relationship between MA and aggression, structural MRI 
studies have shown extensively that the PFC is affected by MA use (Alaee et al., 2014; Bae et 
al., 2006; Kim et al., 2006; Mackey et al., 2014; Nakama et al., 2011; Schwartz et al., 2010). 
MA and its structural brain changes might therefore play a role in the emergence of 
aggression.  
 
These studies are an example of many theories and findings about the relationship of MA 
and aggression but there is not yet consistent agreement. Furthermore, there are no studies 





Neurobiology of aggression  
The neurotransmitter DA plays an important role in reward related behaviour, motivation, 
cognition and movement (Arias-Carrion & Poeppel, 2007). As discussed in the neurobiology 
of MA abuse section, DA additionally is related to addiction. 5-HT, which is thought to play a 
role in depression given that serotonin-reuptake inhibitors are effective in this condition, also 
has significance in aggression. Here I am going to highlight interactions between DA and 5HT 
and their link to aggressive behaviour. Of course, there are other hormones like testosterone, 
which also play an important role in mediating aggressive behaviour, but for lucidity, I will 
focus on DA and 5-HT.  
Impulsive aggression is associated with low levels of 5-HT and 5-HT-receptor density 
(Davidson et al., 2001; Sekine et al., 2006; Seo, Patrick & Kennealy, 2008). As outlined above, 
chronic MA administration is followed by nerve terminal damage resulting in low 5-HT levels 
in MA abuse. It has been demonstrated that 5-HT has an inhibiting effect on aggression 
(Volavka, 1999) and lower serotonin levels correlated with more aggressive behaviour 
(Coccaro, 1989; Sekine et al., 2006). Moreover, Sekine et al. (2006) found an inverse 
correlation between 5-HT receptor density and aggressive behaviour, which also correlated 
with the duration of MA abuse. In addition, low levels of 5-HT could be correlated with 
decreased activation of the anterior cingulate cortex in individuals with impulsive 
aggressiveness (Frankle et al., 2005).  
 
Interestingly, the PFC has a high density of serotonin type 2 receptors (Biver et al., 1996) and 
5-HT increases activity in the PFC (Mann et al., 1996). Seo, Patrick & Kennealy (2008) 
reviewed studies investigating this link between hypodynamic 5-HT states and decreased PFC 
activation in aggressive individuals. They concluded that “decreased serotonergic 
neurotransmission in brain regulatory systems such as the PFC and the anterior cingulate 
cortex may be a major neurobiological deficit that leads to inhibitory dysfunction and 
aggressive behaviours”. I will focus on the anatomical regions involved in aggression in the 
next section.  
 
In contrast, high DA levels are consistently associated with elevated impulsive aggression. 
Mice and human study findings support a direct link between high DA and aggressive 
behaviour (Anstrom, Miczek  & Budygin, 2009; Couppis & Kennedy, 2008; Ferrari et al., 2003; 
Harrison, Everitt & Robben, 1997).  An intervention study by Couppis et al. (2007) found that 




scanned 32 healthy volunteers with PET after administering a low dose of amphetamine 
(AMPH) or a placebo. The AMPH administration resulted in an increase of DA in the striatum. 
In addition, higher scores on the Barrett Impulsiveness scale were found in the AMPH group 
with AMPH-induced DA release.  
 
5-HT levels have a strong interaction with DA levels. Daw et al. (2002) and Wong et al. (1995) 
proposed a reciprocal interaction between 5-HT and DA supporting the findings above. As 
mentioned before Seo, Patrick & Kennealy (2008) proposed a model where dysregulation of 
5-HT (low) and DA (high) especially in the PFC predispose individuals to impulsive aggression. 
They went even further and suggested “Substance abuse associated with impulsive 
aggression is understood in the context of dopamine dysregulation resulting from 
serotonergic deficiency”.  
 
Neuroanatomy of aggression  
Asymmetry Model 
It has been posited that the right and the left-brain hemispheres play different roles in 
emotion and behaviour. Tullett, Harmon-Jones & Inzlicht (2012) showed in an EEG study that 
higher right frontal activation predicts empathic behaviour. Previous studies showed that 
right frontal asymmetry correlated with stronger negative affect and people are more likely 
to develop depression (Henriques & Davidson, 1990; Nusslock et al., 2011; Schaffer, Davidson 
& Saron, 1983; Tomarken et al., 1992; Wheeler et al., 1993). The left side of the brain on the 
other hand is playing an important role in happiness and anger (Coan, Allen & Harmon-Jones, 
2001; Davidson, Schaffer & Saron, 1985; Harmon-Jones & Allen, 1998).  
 
One idea is that of an approach- left brain- and avoidance –right brain- motivation model of 
frontal asymmetric activation. Approach motivation is explained by Schutter & Harmon-Jones 
(2013) by a motivation to ‘experience a positive outcome’ while avoidance motivation seeks 
‘not to experience a negative outcome’. In their very recent review, they discussed EEG 
studies, which link left brain dominance to anger and aggressive behaviour. A review by 
Hecht (2011) shows that left-brain dominance is found in psychopaths and Keune et al. (2012) 
supported these findings in a sample of violent prisoners. Similar results of left-approach and 
right-avoidance motivation were demonstrated in fMRI (Berkman & Lieberman, 2010), PET 
(Tomer et al., 2008) and transcranial magnetic stimulation studies (TMS) (D’Alfonso et. al, 




Czobor & Volavka (1991) of individuals with antisocial personality disorder. The authors 




The CC, an important WM bundle, connects the left and the right hemispheres of the brain. 
Anatomically it is divided from anterior to posterior into the genu, corpus, isthmus and 
splenium. The anterior part – the genu- connects both PFC’s with each other. The CC has a 
mainly inhibiting role in the submission of information from one side to the other described 
as transcallosal inhibition (TCI). A very interesting transcranial magnetic stimulation (TMS) 
study was conducted by Hofman & Schutter (2009). They demonstrated in a healthy 
population that an aggressive personality style as assessed by the Buss & Perry Aggression 
Questionnaire (Buss & Perry, 1992) has a direct relationship with a dominant left-sided 
transcallosal hemispheric inhibition of the right frontal cortex.   
 
WM abnormalities in the CC are commonly found to be linked to aggressive behaviour (see 
review by Schutter & Harmon-Jones, 2013). In a preliminary study using PET, Raine et al. 
(1997) reported lower glucose metabolisation in the CC in a population of violent murderers 
as compared to controls. To assess structural differences in the CC in a group of psychopathic 
individuals they later conducted a MRI study (2003). Compared to controls Raine et al. found 
higher WM volumes in the CC in psychopathic individuals, and increased volumes were 
associated with affective and interpersonal deficits.   
 
In conclusion, the left hemisphere may be related to approach motivation and to generating 
aggression and anger. The CC may play an inhibiting role involving information transmission 
between the two hemispheres. More left dominance, by either higher left sided activation 
or higher left to right inhibition, appears linked to aggression. Remarkably, as I will discuss in 
the next section, we find structural changes especially in prefrontal WM regions and the CC 
in MA abuse, which could perhaps explain the higher aggression levels found in individuals 
with MA abuse (Alicata et al., 2009; Chung et al., 2007; Kim et al., 2009; Oh et al., 2004; Tobias 






‘Frontal lobe syndrome’ is a well-known condition, which can result in inappropriate 
aggressive behaviour (Silver & Yudofsky, 1987). The most famous example of this would be 
the case of Phineas Cage. In the middle of the 19th century, the railroad worker was injured 
by an iron rod penetrating his head damaging his complete left frontal lobe (Barker, 1995; 
Guidotti, 2012). Surprisingly, he did not just survive the injury but was able to walk and speak 
only minutes later (Harlow, 1848). Although he lived another twelve years, close friends and 
family members described him as not being himself after the accident. The former hard 
working and responsible 25-year old became aggressive and could not hold a job (Barker, 
1995; Harlow, 1848). Although some of the mental changes have been exaggerated after 
Phineas’ death, it was the first neuroscientific case suggesting behavioural changes out of 
localized brain damage.  
 
The ventromedial PFC (VMPFC) is situated in the inferior frontal lobe. It plays a role in reward 
related learning, memory and emotion regulation, especially when behaviour is supposed to 
change (Rolls, 2004). Therefore, lesions in this part of the PFC have been associated with 
“disinhibited and social inappropriate behaviour” (Berlin, Rolls & Kischka, 2004). Grafman et 
al. (1996) studied veterans of the Vietnam War who suffered penetrating injuries to the 
VMPFC and examined their aggressive behaviour using self-reports and family observations. 
Higher aggression scores, especially for verbal aggression, were seen in participants with 
VMPFC lesions compared to controls and patients with lesions in other brain regions.  
 
The right ventrolateral PFC (rVLPFC) plays an important role in “self-control” as Cohen, 
Berkman & Liebermann (2012) illustrate. They define “self-control” as the ability to inhibit 
impulses and urges. The activation of the rVLPFC has been correlated in several studies with 
actively suppressing emotion and the magnitude of activation correlated with the degree of 
emotional self-control (Cohen, Berkman & Liebermann, 2012). A reduction in VLPFC 
activation was found in an affect matching task by Payer et al. (2008) in individuals with MA 
abuse. They argued that diminished socio-emotional integrity could lead to the 
inappropriate, aggressive behaviour often shown by individuals who abuse MA. 
 
Connection between the PFC and the limbic system 
The limbic system is a functional and structural interconnected system with strong 




important functions in our emotional experience and behaviour. Basic drives like the flight 
or fight reaction are implemented in this phylogenetically ancient system of the brain. The 
amygdala as part of the limbic system is mediated by strong connections with the PFC. 
Lesions in the PFC resulting in less inhibition of the amygdala or lesions in the amygdala itself 
could be associated with impaired emotion regulation in previous studies (see Review: Seo 
& Patrick, 2008 or Davidson, Putnam & Larson, 2000; Hoptman, 2003; Payer et al., 2011). The 
amygdala is important for fear processing. It also plays a role in recognizing angry faces. 
Adolphs, Tranel & Damasio (1998) asked three patients with complete bilateral amygdala 
damage to judge faces for trustworthiness and approachability. All three of them judged the 
most untrustworthy looking faces as very approachable showing that their social judgement 
is impaired. This misinterpretation of social cues and abnormal fear processing can lead to 
aggressive behaviour (Hoptman, 2003). 
 
Cingulum 
Likewise, the cingulum is found to be associated with aggressive behaviour and drug abuse 
(Kim et al., 2011; Payer et al., 2011; Sekine et al., 2006). The cingulum contains fibres 
projecting from the cingulate cortex to the entorhinal cortex. It follows the C shape around 
the CC from the frontal lobe into the temporal lobe and to the parahippocampal gyrus. The 
anterior part of the cingulum plays a role in emotion regulation and the posterior part in 
memory, attention and visual-spatial skills (Aouizerate et al., 2007).  
 
Several studies investigated the relationship of the cingulum and aggression especially in 
drug abuse. Sekine et al. (2006) showed in a PET study a correlation between 5-HT density 
and aggression in anterior cingulate areas in individuals with MA abuse. In addition, Payer et 
al. (2011) found that hyperactivity in the anterior cingulate cortex relates to hostility in MA 
dependence using fMRI. Kim et al. (2011) focused on the posterior cingulate cortex and 
parahippocampal gyrus and argued that hyperactivity in these regions could be a cause of 
“altered emotional experience in social interactions” in their group of individuals with MA 
abuse.  
 
Furthermore, the cingulum plays a role in drug craving and is part of the reward system of 
the brain. Wang et al. (2007) found amongst other regions hyperactivation in in the anterior 
cingulate gyrus in cigarette smokers who experienced cravings after abstinence. In a DTI 




left anterior cingulum and physical nicotine dependence. In a resting state fMRI study, Janes 
et al. (2014) found that a rise in nicotine craving was associated with an increase of 
connectivity in the medial and orbital PFC including the anterior cingulate gyrus.  
 
DTI studies on aggressive behaviour 
Next, I will discuss studies investigating aggressive behaviour using DTI. To my best 
knowledge there is no study yet comparing WM changes detected with DTI and aggressive 
behaviour in MA dependence. First, there are only a few studies correlating WM integrity 
directly to aggressive behaviour in other clinical populations or healthy controls. Second, as 
I will show, several studies investigated WM changes in psychiatric disorders, which are 
strongly associated with disorders characterized by aggressive and violent behaviour such as 
conduct disorder, psychopathy, and antisocial personality disorder, although in such work 
there is no direct correlation with aggression. And third, I will show studies demonstrating 
an association between WM impairment and impulsivity, given that impulsivity is in turn 
correlated with aggression (Hoptman et al., 2002). 
 
All but one study of Beyer et al. (2014) found a correlation between decreased WM integrity 
and increased aggressive behaviour. Hoptman et al. (2002) demonstrated in their DTI study 
of individuals with schizophrenia a correlation between lower FA values in the right inferior 
frontal WM and aggression scores on a self-report questionnaire. Similar associations 
between anger and hostility and inferior frontal WM changes were found by Ruesch et al. 
(2007) in women with borderline personality disorder and comorbid attention deficit 
hyperactivity disorder. They observed increased MD in the right inferior frontal WM, which 
correlated positively to self-report measures of anger and hostility.  
Peper et al. (2014) studied WM integrity in a group of healthy adolescents and found a 
correlation between higher scores on the Buss & Perry Aggression Questionnaire and 
decreased FA, increased RD (radial diffusivity), LD (longitudinal diffusivity) and MD in the 
fronto-temporal-subcortical network.  A study conducted by Saxena et al. (2012), 
investigating aggression in bipolar disorder, found a negative correlation between lower FA 
values in the anterior commissure and genu of the CC, and aggressive behaviour. The 






There is one study examining WM integrity in the uncinate fascicle and trait aggression in 
healthy adults using DTI. Since the inhibitory control of the OFC over the amygdala is relevant 
for emotion regulation it was assumed that disruptions in that connection could play a role 
in aggression. Beyer et al. (2014) found no relationship between trait aggression and the 
connectivity between the OFC and amygdala (= uncinate fascicle). The authors argue that 
perhaps fronto-limbic disconnectivity can only be shown in pathologic aggression as shown 
in studies below.  
 
It is well established, then, that WM impairment plays a role in psychiatric disorders, which 
are characterized by displaying patterns of aggressive behaviour and emotion regulation 
deficits. As discussed above, the following studies did not specifically correlate imaging 
findings with aggression, but aggressive behaviour plays a major role in these disorders.  
 
Passamonti et al. (2012) found changes in the anatomical connection between the OFC and 
the amygdala in participants with conduct disorder. FA values were increased in the 
uncinated fascicle compared to healthy controls. Results by Craig et al. (2009) on the other 
hand showed reduced FA in the right uncinate fascicle but not in the left in psychopathy. The 
authors found a trend towards a negative correlation of behavioural scores and FA values in 
the right uncinate fasciculus. Using voxel-based analyses Sundram et al. (2012) found even 
broader changes throughout the brain in a sample of participants with antisocial personality 
disorder. The authors found, consistent with Craig et al. (2009), reduced FA in the right 
uncinate fascicle. Furthermore, they showed reduced FA bilaterally in the genu of the CC, the 
right anterior corona radiata and right anterior limb and genu of the internal capsule and the 
right inferior fronto-occipital fasciculus. The FA values in the frontal lobes of individuals with 
antisocial personality disorder also correlated negatively to antisocial behavioural scores. 
Again consistent with Craig et al. (2009), reduced FA in the genu of the CC was found by 
Sundram et al. (2012) in their sample of adults with antisocial personality disorder and these 
FA changes correlated negatively with psychopathy scores.  
 
One very recent study from Zhang et al. (2014) revealed that impulsivity was associated 
positively with increased FA values in the genu and body of the CC and the right superior 
corona radiata in a group of adolescent with conduct disorder. On the other hand, Moeller 
et al. (2005) found a negative correlation between FA values in the anterior CC and 




adolescent participants of Zhang et al. could be due to reactive gliosis and different 
maturation in the adolescent brain. This is supported by findings from a study by Colby et al. 
(2012) who similarly found increased FA values in children with prenatal MA exposure in the 
anterior corona radiate and genu of the CC. The authors argue that higher FA values could be 
due to compensatory mechanisms because of MA damages to the developing brain.  
 
Taken together, WM changes in frontal brain areas seem to exist across diagnoses in samples 


























1.4 Hypothesis and Objectives 
Several neuroimaging studies showed dysregulation of frontal lobe function or frontal 
structural changes in impulsive and violent behaviours. Reduced regulation of the frontal 
cortex over subcortical structures might be a risk factor for development of aggression. The 
altered connectivity between frontal and subcortical especially limbic regions might be due 
to WM impairment.  
 
Based on the literature review, the aim of this study was to delineate possible relationships 
between WM changes and aggression in MA dependence. I therefore compared WM 
integrity of abstinent individuals with MA dependence with a group of healthy control 
subjects using DTI. As a measurement of aggressive behaviour, I used the self-report Buss & 
Perry Questionnaire. The resulting aggression scores were then correlated with WM 
impairment to assess a possible association between the two. 
 
The hypotheses were that: 
1. The MA group would show lower FA and λ║ values, as well as higher MD and λ┴ values 
compared to healthy controls, reflecting structural WM changes in the former group. 
2. Buss & Perry Questionnaire self-report scores would be higher in individuals with MA 
dependence than in healthy controls. 
3. WM damage, especially in frontal lobe areas, would be significantly associated with 
aggressive behaviour in individuals with MA dependence. 
 
To investigate WM changes in the two study groups, I chose both a theory-based region of 
interest (ROI) and an explorative whole-brain analytic approach. As an explorative method, I 
compared the MA group and the healthy controls in a tract-based spatial statistical (TBSS) 
analysis as explained in the Methods chapter.  
 
As previous research shows, WM changes in MA abuse as well as in aggressive behaviour are 
commonly found in frontal areas. For the ROI analysis, I therefore chose to investigate WM 
tracts in the frontal areas of the left and right hemisphere respectively. Based on the John 
Hopkins University (JHU) ICBM-DTI-81 white-matter labels atlas (Mori et al., 2008), I included 





(1) the genu of the Corpus Callosum (CC)  
The left and the right side of the brain are connected by a WM bundle called the CC. 
Anatomically it is divided from anterior to posterior into the genu, corpus, isthmus and 
splenium. The CC, especially the genu as a connection of the prefrontal cortices of the 
hemispheres, plays an important role in regulating emotions (Nowicka & Tacikowski, 2011; 
Schutter & Harmon-Jones, 2013).  
 
(2) the cingulum (CgG; CgH)  
The cingulum forms the WM core of the cingulate gyrus. It is an association bundle with long 
and short fibres carrying information from the cingulate gyrus to the hippocampus. It also 
links the prefrontal and the parahippocampal cortices (Goldman-Rakic, Selemon & Schwartz, 
1984). The JHU ICBM-DTI-81 white-matter labels atlas (Mori et al., 2008) divides the cingulum 
into two parts - the cingulum in the cingulate gyrus (CgC) and in the hippocampal region 
(CgH). They are divided at the axial level of the splenium of the CC.  
 
(3) the uncinate fasciculus 
The uncinate fasciculus connects the orbito-frontal lobe with the hippocampus and amygdala 
in the anterior temporal lobe. This tract is considered part of the limbic system and WM 
changes are commonly found to be associated to aggressive behaviour as discussed above.  
 
In the next chapter, I am going to explain the recruitment process as well as questionnaires 
and statistical procedures used in this research. It also contains an introduction to DTI 

















Recruitment of participants with MA dependence was undertaken in a number of drug 
counselling and rehabilitation facilities in the greater Cape Town area. Healthy control 
subjects were recruited from the same communities as the individuals with MA dependence, 
through word of mouth and by means of flyers to match them as close as possible in terms 
of gender, age, years of education, ethnicity and social circumstances. All participants were 
right handed, fluent in English and between 18 and 40 years of age. Inclusion criteria for the 
MA group were 1) diagnosis of MA dependence on the Structured Clinical Interview of DSM 
IV Disorders (SCID-I), and 2) current drug abstinence.  Exclusion criteria for all participants 
were 1) substance dependence (except nicotine for all participants and except MA for the 
MA group) 2) current or a history of a psychiatric disorder 3) severe medical or neurological 
illness or trauma including head injuries, and 4) a history of seropositive testing for HIV (HIV 
status was not tested in the study out of ethical reasons). Additionally, participants with 
conditions which would prohibit MRI scanning like 5) metal implantation or 6) claustrophobia 
were excluded. Until 2014, the umbrella study screened 174 participants, of which 83 had to 
be excluded due to ineligibility, 6 participants withdrew their consent, and 15 participants 
were lost in the follow up process. During my affiliation with the study in 2014, 26 
participants were screened, of which 5 did not meet our inclusion criteria and were excluded. 
In total, we found 91 participants to be eligible. 11 scans were excluded due to quality issues 
(head movement, distortion etc.). Finally, we included scans in the data analysis of 40 
participants with MA dependence and 40 matched healthy controls.  
This fairly matched our beforehand determined sample size of 84 participants. Following 
output parameters were acquired using power calculations for two tailed t-test in GPower 
analysis software (input parameters: Alpha= 0.05; 1-ß = 0.95; Effect size d= 0.8 (large effect); 
Allocation ratio N2/N1: 1):  
Critical t: 1.9893186 
Total sample size: 84  
Actual power 0.9518269.  
  
Participants received supermarket food vouchers for the interview and the brain scan as 
compensation for food and travel expenses. Before individuals entered the study informed 
consent was obtained in writing, after insuring that the participant fully understood the study 





To determine eligibility for participation according to the study’s inclusion and exclusion 
criteria all participants underwent a clinical assessment. This was carried out by a trained 
clinician in the Department of Psychiatry and Mental Health using the Structured Clinical 
Interview for DSM-IV Disorders Researchers version (SCID-Ι for DSM-IV-TR) (First et al., 2002). 
The SCID is a semi-structured interview, which focuses on diagnosing Axis I disorders. The 
language of the SCID is intended to be understood by individuals with a grade 8 level of 
education or higher. Even though it was not an exclusion criterion, all of the participants 
completed at least grade seven. 
We included the following modules: 
A. Mood Episodes  
B. Psychotic and Associated Symptoms 
C. Psychotic Disorders 
D. Mood Disorders 
E. Substance Abuse 
F. Anxiety Disorders 
G. Somatoform Disorders 
H. Eating Disorders 
 
Demographic details, including ethnicity, language, employment status, and number of years 
of schooling completed, were documented. Additionally, we kept a record of drug use 
measures, together with life-time use of all major drug types, MA use onset, duration of MA 
use, and duration of MA abstinence. 
 
2.2 Behavioural Measures  
A questionnaire by Buss & Perry (1992) designed to assess aggressive behaviour was given to 
the individuals with MA dependence and healthy control participants. The questionnaire 
measures four dimensions of aggression: Physical Aggression, Verbal Aggression, Anger, and 
Hostility. These are assessed by 29 statements the participant has to rank as "extremely 
uncharacteristic of me" to "extremely characteristic of me" on a 5-point scale. Questions for 
Physical Aggression include e.g., “I have become so mad that I have broken things”; Verbal 




my friends think I am a hothead” and Hostility “I am suspicious of overly friendly strangers”. 
The subscales Physical Aggression with 9 items and Verbal Aggression with 5 items represent 
the “disinhibited” behavioural aspects, Anger including 7 items the affective and Hostility 
with 8 items the “inhibited” cognitive aspect of aggression (Anderson & Bushman, 2002). 
Scores range from 29 points to a maximum score of 145 points. Lower scores indicate a lower 
aggression level and higher scores more aggressive behaviour.  
 
The questionnaire is widely used and reliability and validity have been demonstrated 
repeatedly (Bernstein & Gesn, 1997; Harris, 1997; O’Conner, Archer &Wu, 2001; Tremblay & 
Evart, 2005). Although some researchers recommend removing some items of the 
questionnaire (Harris, 1995; Vigil-Colet et al., 2005), the psychometric properties are sound. 
There have also been a few studies, which tested the generalizability of the questionnaire 
internationally with reassuring results (Fossati et al., 2003; Gerevich, Bácsakai & Czobor, 
2007; Nakano, 2001; von Collani & Werner, 2005). On the other hand, Becker (2006) states 
that influences of social desirability when answering the questions are a weakness of the 
test. Then again, Darke et al. (1998) have shown that the self-report measures in substance 
abuse participants tend to be accurate “when compared to biomarkers, criminal records and 
collateral interviews”. 
  
2.3 DTI analysis 
Brain imaging sequences 
Brain imaging was conducted using a 3T Siemens Magnetom Allegra at the Cape Universities 
Brain Imaging Centre (www.sun.ac.za/cubic). Full-brain DTI images were acquired with the 
following sequence: orientation=transversal; slices=70; distance factor=0; voxel size=2x2x2 
mm3; TR=9500ms; TE=88ms; diffusion directions=30; b-value=1000s/mm2; 4 reference b0 
scans; 120x120 matrix; FOV=240mm; FOV phase=100%; scan time=5:33minutes, repeated 
three times.  
 
Scans were checked for structural abnormalities for both groups by a study independent 
radiologist. To control for acute drug use a five panel urine screen was performed before the 
scan testing for MA, amphetamines, opioids (morphine), Tetrahydrocannabinol (THC) and 






The Oxford Centre for Functional Magnetic Resonance Imaging of the Brain software library 
(FSL) (Smith et al., 2004) was used for analysing the DTI data.  
Fractional anisotropy (FA), a measure of the directionality of water diffusion in WM fibres, 
mean diffusivity (MD), a direction-independent measure of local water diffusion, and the 
eigenvalues (λ1, λ2, λ3) were calculated. From the eigenvalues, the perpendicular Diffusivity 
(λ┴) was determined, being the mean of the two perpendicular eigenvalues λ2 and λ3, as well 
as the parallel Diffusivity (λ║), being λ1. These measures were subsequently put into FSL’s 
Tract Based Spatial Statistics (TBSS) tool (Smith et al., 2006), which uses robust methods of 
quantifying localised WM differences between study groups.  
 
To prepare the data for use in FSL, DICOM images were converted to NIfTI format using the 
program Mcverter in Matlab. An in-house script was used following the pre-processing steps 
of TBSS. This script embodied FSL analysis tools, specifically Eddy correction, Brain Extraction 
(BET) and DTIfit as explained below (Smith et al., 2004). Eddy correction was used to correct 
for head movement and distortion caused by eddy currents of the gradient coils of the MRI 
machine. For creating a brain mask and for removing skull and meninges from our data, 
images in a second step got brain-extracted using BET [Brain Extraction Tool] at the 
recommended threshold of 0.3.  The script continues with fitting a tensor model to each 
voxel of the data using DTIfit within the FDT toolbox [Functional MRI of the Brain Diffusion 
Toolbox] providing us with the following output: 
 
V1 - 1st eigenvector 
V2 - 2nd eigenvector 
V3 - 3rd eigenvector 
λ1 - 1st eigenvalue  
λ2 - 2nd eigenvalue 
λ3 - 3rd eigenvalue 
λ┴ - perpendicular diffusivity  
MD - mean diffusivity 
FA - fractional anisotropy 




After pre-processing was completed, a visual quality check for warping and segmentation 
defaults was performed.   
 
Two different approaches of comparison of WM differences between the two groups were 
carried out; an explorative whole-brain voxel wise analysis and a theory based ROI method.  
ROI analysis was performed at three prefrontal regions defined by the JHU ICBM-DTI-81 
white-matter labels atlas (Mori et al., 2008).   
 
I chose TBSS within FSL as an analytic tool, because it resolves potential alignment and 
smoothing issues encountered with other analysing methods, like voxel-based morphometry 
(VBM), in two steps. First, approximate nonlinear registration is performed as described 
below. Following, a skeleton of all WM tracts common to the study group is generated and 
each subject’s DTI measures are then projected onto the skeleton so that each skeleton voxel 
takes the value from the centre of the nearest tract.  
However, since DTI relies on the microstructural architecture of WM, in areas with crossing 
fibres, TBSS is still problematic and results have to be interpreted carefully.  
 
TBSS  
For voxel wise statistical analysis I used following codes as provided within TBSS (Smith et al., 
2006).  
tbss_1_prepoc *.nii.gz 
The first preprocessing step in TBSS abrades the images and zeros the end slides.  
tbss_2_reg -T 
Then, all FA images were aligned into 1×1×1mm3 Montreal Neurological Institute- 152 
(MNI152) common space using the nonlinear registration tool FNIRT within FSL. The –T 
option in the code uses the FSL standard template FMRIB58_FA as registration surface for all 
subjects FA images (Jenkinson & Smith, 2001). 
tbss_3_postreg -S 
Following, a mean FA image, from all the subjects FA images combined, was created. To check 
for effective registration the mean FA image was inspected following all major WM tracts. 
Next, the mean FA image was thinned and skeletonized resulting in a mean_FA_skeleton 




alignment results, every single FA image (all_FA) was loaded onto the mean_FA_skeleton for 
quality control using FSLview.  
 
Figure 1: mean_FA_skeleton. This shows the major WM tracts of all subjects of both groups. 
 
tbss_4_prestats 0.2 
In the last step, the threshold for FA values was set at 0.2 to ensure that only voxels within 
WM were used in the next projection step (Smith et al., 2006). Now each single FA image was 
projected onto the mean_FA_skeleton by choosing the FA value closest to the tract centre. 
As an outcome, I got a 4D image file with all the projected skeletonised FA data called 
all_FA_skeletonised with the fourth dimension being the subjects. This file was used in voxel-
wise cross-subject statistics for further analysis.  
 
 
Figure 2: all_FA_skeletonised. This shows an image of one subject’s skeletonised FA map. 
 






This script combines all steps within TBSS above and uses the mean_FA_skeleton as a 
projection for the all_non_FA image files resulting in an all_non_FA_skeletonised image for 
each measure subsequently.   
  
Randomise 
I used Randomise version 2.0 from the FSL toolbox for voxel-wise permutation-based 
nonparametric analysis (Nichols and Holmes, 2002) on the skeletonized FA, MD, λ║ and λ┴ 
data to identify WM differences between our two study groups. Design matrix and design 
contrast (Control > MA; MA > Control) files were created using the General linear model 
setup (Glm GUI) with study group as independent variable and age and gender as covariates. 
I used 5000 random permutations as recommended by the FSL user guide to test our 
contrasts at a significance level of p < 0.05. Multiple comparisons correction using threshold-
free cluster enhancement (TFCE) (Smith and Nichols, 2009) was performed with a cluster-
wise significance level at p < 0.05.  
  
The outcome was a set of files containing raw t-test statistic images (unthresholded) and 
TFCE p-value images fully corrected for multiple comparisons across space. I then masked 
our raw t-test statistic images with significant voxels of the fully corrected images (corrp) 
respectively using fslmaths from the toolbox on a threshold of 1-p (0.95).     
fslmaths MA_output_tfce_corrp_tstat1 -thr 0.95 -bin -mul MA_output _tstat1 MA_output 
_thresh_tstat1  
The above command resulted in two threshold t-test statistic images, which then could be 
used to extract clusters across the brain. 
 
The last step provides us with a table containing information about the cluster index, number 
of voxels in one cluster, maximum voxel intensity and location in MNI space. These 
coordinates could then be used to localize WM changes using the JHU ICBM-DTI-81 white-
matter labels atlas (Mori et al., 2008). 
cluster --in= Meth_output _thresh_tstat1 --thresh=0.05 --oindex= Meth_output 




For visualizing the results, FSLview was used by overlaying the resulting clusters over a 
standard brain template (MNI152_T1_1mm_brain). 
 
Region of Interest analysis 
In the second approach to delineate WM differences between the two groups, I used a ROI 
method. ROI masks for the three frontal predefined WM regions labelled by the JHU ICBM-
DTI-81 white-matter labels atlas (Mori et al., 2008) were created using an in-house script. FA, 
MD, λ║ and λ┴ values were extracted from following regions for the left (LH) and right (RH) 
hemisphere respectively:   
(1) the genu of the CC,  
 
Figure 3: Region of Interest mask for the genu of the corpus callosum.  
  
(2) the cingulum,  
 (2.1) cingulate gyrus section (CgC), 
 




(2.2) hippocampal section (CgH), 
 
Figure 5: Region of Interest mask for the hippocampal section of the cingulum. 
 
(3) and the uncinate fasciculus. 
 
Figure 6: Region of Interest mask for the uncinate fasciculus.  
 
The advantage of this computed form of ROI extraction is that there is no arbitrary drawing 
of ROI seeds, which could influence the results. The script compiles a table with all subjects 
measured values for FA, MD, λ║ and λ┴ for each region of interest respectively. This table was 
subsequently put into SPSS for statistical analysis.  
 
2.4 Statistical analysis 
All statistical analyses were done in SPSS (version 22). All data was tested for normal 
distribution using the Shapiro Wilk test. Group comparison of demographic data was done 
using the Mann-Whitney-U test for non-parametric data and Pearson Chi-square test for 




Buss & Perry Questionnaire with total score and subscales as ‘dependent factors’ and study 
groups as ‘fixed factor’. Given a significant overall test, individual questionnaire scores were 
compared between groups using independent 2-sample t-test. DTI measures were analysed 
with Mann-Whitney-U test for non-parametric data. Spearman correlation was used to 
investigate the relationship of aggression scores and WM differences as well as MA use 
measures (onset of use, duration of use and abstinence) and WM differences. To correct for 
multiple comparison, I used the 2-staged linear step up procedure of the false discovery rate 
control (FDR) (Benjamini, Krieger and Yekutieli, 2006) for each WM structure. The criterion 
for statistical significance for all tests was at p < 0.05 (2-tailed). 
 
2.5 Ethics statement 
The study was conducted in accordance with the guidelines of The Declaration of Helsinki 
(Edinburgh 2000) and approved by the Human Ethics Research Committee of the Faculty of 
Health Sciences at the University of Cape Town University (HREC 395/2014). The study is part 
of an ongoing methamphetamine umbrella study (HREC 340/2009). 
 
Before entering the study, participants gave informed consent by signing a consent form. The 
study was explained to every participant and it was made clear that the study was entirely 
voluntary and that they could withdraw their consent at any time during their participation. 
It was also explained that all information was kept confidential, ensuring that we used study 
codes instead of names for further processing. The study did not entail significant direct risk 











Table 1 presents demographic data of the MA and control group. Participants did not differ 
significantly in gender, age, alcohol or cannabis consumption. However, the MA group had 
less years of education (p= 0.001) and more tobacco (p=0.007) and methaqualone (p=0.026) 
consumption then the control group. Individuals with MA dependence were in median 21 
days abstinent. The median duration of MA use was 6.5 years and the median age MA abuse 
was started was 17 years old.  
 
Table 1: Demographic and methamphetamine use measures 
 
*significant differences between Groups; MA= methamphetamine group; CTRL= control group; N= numbers 
 
 
3.2 Behavioural Measure 
Four participants in the control group did not complete the Buss & Perry Questionnaire.  
Multivariate analyses showed a significant difference between groups (p<0.001) so that 
independent t-tests were used for individual group comparisons. Mean aggression scores for 
Anger (p<0.001), Physical Aggression (p=0.032) and Total score (p=0.021) were significantly 
higher in the MA group then in the control group. However, Anger showed a medium effect 
size (d= 0.41) and Physical Aggression (d=0.25) and Total scores (d=0.26) a low effect size. All 
group differences survived FDR correction. Study groups showed no differences in Hostility 
or Verbal Aggression scores. Despite the fact that these are ordinal data, we conducted an 
 




TEST FOR GROUP 
DIFFERENCE 
    
MALE/FEMALE, N 29/11 29/11  χ2(1)=.000, p=1.0 
AGE IN YEARS, MEDIAN (RANGE) 25.5 (18-38) 25 (18-38) U=762.5, p=.721 
LEVEL OF EDUCATION IN YEARS, MEDIAN (RANGE) 10 (8-15) 12 (9-14) U=481.0, p=.001* 
TOBACCO SMOKERS, N 34 22 χ2(1)=8.571, p=.007* 
ALCOHOL CONSUMERS, N 21 17 χ2(1)=0.802, p=.502 
CANNABIS USERS, N 9 14 χ2(1)=1.526, p=.323 
METHAQUALONE USERS, N 5 0 χ2(1)=5.475, p=.026* 
 
MA USE MEASURES 
     
AGE OF ONSET IN YEARS, MEDIAN (RANGE) 17 (12-32)   
DURATION IN YEARS, MEDIAN  (RANGE) 6.5 (2-19)   




analysis of covariance (ANCOVA) test to estimate the effects of education on aggression 
scores; Pillai’s trace test showed no statistically significant effect for any of the subscales 
(F(5,69)=0.698, p=0.627).  
 
Table 2: Buss & Perry Questionnaire scores 
 
Scores in Mean ± Standard Deviation, MA= methamphetamine group, CTRL= control group, N=number 
 
 
3.3 DTI analysis  
TBSS analysis within FSL 
Between-group voxel wise whole-brain comparison revealed higher MD values in the right 
superior corona radiata in the MA group, compared to healthy controls. The cluster 
containing 250 voxels was found in the right superior corona radiata at x/y/z = 18/-22/55. 
Significance levels within Randomize were set at p<0.05 and results were corrected for 
multiple comparisons within the program.  
 
 
Figure 7:  Results: TBSS analysis. Increased mean diffusivity values in the right superior corona radiata in the 
methamphetamine group.  
 




GROUP DIFFERENCE EFFECT SIZE 
PHYSICAL AGGRESSION  26.63 ± 8.625 22.58 ± 7.36 t(74)= 2.19, p= .032* d= 0.25 
VERBAL AGGRESSION 16.30 ± 4.23 15.72 ± 3.44 t(74)= 0.65, p= .519 d=0.08 
ANGER 20.88 ± 5.8 16.11 ± 4.73 t(74)= 3.90, p< .001* d=0.41 
HOSTILITY 24.68 ± 7.18 22.14 ± 7.89 t(74)= 1.47, p= .147 d=0.17 





Region of Interest analysis 
Table 3 shows the median FA, MD, λ┴ and λ║ values for the three WM regions of interest. I 
found significantly lower FA values in the left cingulum (CgC) (U=545.0, p=0.014, d= -0.27) of 
individuals with MA dependence but not in the right CgC. FA values in the left CgC did not 
survive FDR correction. I also found significantly higher MD values in MA users compared to 
healthy controls bilateral in the hippocampal region of the cingulum (RH: U=541.5, p=0.012, 
d=- -0.28; LH: U=550.5, p=0.016, d= -0.27), but only the effects in the RH survived FDR 
correction. MD (U=439.5, p=0.001, d= -0.39) and λ┴ (U=561.5, p=0.021, d= -0.26) values in 
the genu of the CC were higher in the MA group than in controls and both effects survived 
FDR correction. There was no difference in the uncinate fasciculus between the two groups.  




Figure 8: Results: Regions of Interests analysis showing significant results. Red: Increased mean diffusivity and 
perpendicular diffusivity in the genu of the corpus callosum in the methamphetamine group. Blue: Increased 





Table 3: Mean values of DTI measures in predefined Regions of Interest  
 
* = group difference did not survive FDR correction **= group difference survived FDR correction 
FA= fractional anisotropy; MD= mean diffusivity; λ┴= perpendicular diffusivity; λ║= parallel diffusivity 





























































































































Correlational analysis  
Spearman correlational analysis showed a negative correlation between MD in the genu of 
the CC and total aggression score (r= -.315, p=0.047) in MA users but the effects did not 
survive FDR correction. Additionally, λ┴ values in the CC genu inversely correlated with 
Physical Aggression (r= -.366, p= 0.02) and Total score (r= -.380, p= 0.016) in the MA group, 
but likewise, these effects did not survive FDR correction.  
The MD values in the superior corona radiata did not correlate with aggression scores. There 
was no correlation between DTI measures and MA use, i.e. duration, abstinence, or age 
started. Also, no correlation was found between WM integrity and aggression scores in the 
control group.  
 
Table 4: Correlational analysis between corpus callosum and aggression 
 









PHYSICAL AGGRESSION r= -.217, p=.178 r= -.366, p= .02* 
ANGER r= -.226, p=.162 r= -.286, p=.073 






The aim of this study was to delineate the relationship of aggressive behaviour and WM 
structural changes in MA dependence using DTI.  
 
There were three main findings. In line with our first hypothesis, the study showed WM 
changes in individuals with MA dependence compared to controls. A TBSS analysis revealed 
increased MD values in the right superior corona radiata in the MA group. Furthermore, using 
ROI analysis, I found increased MD and λ┴ values in the genu of the CC in individuals with MA 
dependence. MD values were also increased in the MA group in the right hippocampal region 
of the cingulum. Additionally, in line with the second hypothesis, individuals with MA 
dependence showed higher scores of aggression on the Buss & Perry Questionnaire, 
particularly in the subscales of Anger and Physical Aggression. Third, contrary to expectation, 
I did not find a significant correlation of WM changes with aggressive behaviour.  
 
WM changes 
Our finding of increased MD values in the right corona radiata is consistent with several 
previous publications. Tobias et al. (2010) found decreased FA values in the right superior 
corona radiata in individuals with MA dependence. Moreover, impaired WM integrity in the 
superior corona radiata was shown in several studies in cocaine dependent individuals (Bell 
et al., 2011; Lane et al., 2010) and other substance dependences (Jacobus et al., 2013; Qiu et 
al., 2014). Changes in WM structure in the right superior corona radiata, an association fibre 
bundle connecting cortico-limbic structures, have been linked to increased risk taking 
behaviour, and decreased impulse control (Berns, Moore & Capra, 2009; Jacobus et al., 2013; 
Qiu et al., 2014). Unlike Tobias et al. (2010), we did not detect any changes in FA but MD. 
Next, I am going to give possible explanations for that difference.   
 
Controversy exists regarding changes in DTI measures and their structural foundation on a 
neuronal level. However, the observed increase of MD values in our study might be due to a 
decrease in membrane density due to cell degeneration (Beaulieu, 2002; Douaud et al., 
2011). Decreases in FA and increases in MD can happen independently. Changes of FA values 
rely on coherent fibre orientation and it has been shown that in areas of crossing fibres FA 
values might not change (Douaud et al., 2011; Pierpaoli et al., 2001). Furthermore, a loss in 
WM fibres does not affectedly reduce diffusion anisotropy (Pierpaoli et al., 2001). Moreover, 




(Hoare et al., 2010; Stebbins et al., 2007). This might be an explanation of why we did not 
find FA changes in our data.  
Additionally, the diffusivities λ┴ and λ║ can change independently as well. Increased 
perpendicular diffusivity (λ┴) has been associated with demyelination without increased 
parallel diffusivity (λ║) (Song et al, 2002). On the other hand, Beaulieu (2002) argues that the 
cell membranes and not the myelination play the primary role in restricted perpendicular 
water perfusion. Wheeler-Kingshott and Cercignani (2014), however, advice against labelling 
any changes in parallel and perpendicular diffusivities as exact measures for axial 
degeneration or myelin/membrane damages. Nevertheless, even though we cannot use the 
eigenvalues as equivalents of either axonal or myelin damage, they can be used as a 
comparison for overall microstructural WM changes between groups. 
 
Our findings of WM changes in the genu of the CC are consistent with previous studies in MA 
dependence. Kim et al. (2009) showed higher second and third eigenvalues in the genu of 
the CC in MA dependence compared to controls. This is in line with our finding of increased 
λ┴ as the mean of the second and third eigenvalue and increased MD. Contrary to other 
studies (Kim et al., 2009; Salo et al., 2009; Tobias et al., 2010), decreased levels of FA were 
not found in the genu of the CC (see possible explanation above). Similar results of altered 
WM integrity in the genu of the CC is also shown in other substance dependences like cocaine 
(Bell et al., 2011; Lane et al., 2010; Moeller et al., 2005).  
 
To my best knowledge, this study is the first to show WM changes in the right hippocampal 
region of the cingulum in MA dependence. However, it is difficult to compare our findings of 
altered WM integrity in the CgH to other studies because of different segmentation 
procedures. As described above, the JHU ICBM-DTI-81 white-matter labels atlas (Mori et al., 
2008) divides the cingulum into a part adjacent to the CC (CgC) and a part from the splenium 
of the CC inferior reaching into the hippocampal area of the temporal lobe (CgH).  
The right CgH has been linked to substance related problems in maltreated children in a study 
by Huang et al. (2009). In their longitudinal study, they showed that adolescents who 
developed substance dependence had lower FA in the right CgH compared to healthy control 
subjects.   
 
Previous studies showed impaired WM in the anterior cingulum, which we labelled CgC, 




2013; Moreno-López et al., 2012; Pfefferbaum et al., 2009; Sekine et al., 2006). This is not 
surprising given its role in the reward system in the brain. I also found a significant decrease 
of FA in the left CgC in the MA group compared to controls but the results did not survive 
correction for multiple comparison. 
 
In this study, I did not find WM differences in the uncinate fasciculus between the two 
groups. This connection between the PFC and the amygdala has not been linked to WM 
damages in MA dependence before, but impaired WM integrity has been noted in several 
psychiatric disorders with increased levels of aggressive behaviour (Craig et al., 2009; 
Passamonti et al., 2012; Sundram et al., 2012). On the other hand, Beyer et al. (2014) could 
also not show a significant correlation between WM changes in the uncinate fasciculus and 
aggression in healthy participants.  
 
Behavioural measures  
In line with other studies (Cartier, Farabee and Prendergast , 2005; Lapworth et al., 2009; 
Payer et al., 2011; Plüddemann et al., 2010; Sommers & Baskin, 2006; Zweben et al., 2004), I 
found higher aggression levels in individuals with MA dependence compared to controls. 
Especially on the Anger and Physical Aggression subscales, individuals with MA dependence 
showed higher scores than healthy controls.  Physical Aggression and Anger in particular, 
have frequently been linked to substance abuse in previous studies (Chermack et al., 2001; 
Fals-Steward et al., 2002; Murray et al., 2008). 
 
Nevertheless, no conclusive statements regarding causality can be made regarding these 
findings.  Aggressive behaviour, especially Physical Aggression and Anger, are multifactorial 
phenomena. The social and environmental context, childhood and family history of violence 
and abuse, and the direct effects of MA have to be taken into consideration. Higher levels of 
anger may be a reason to take MA rather than a result of the drug use. Thus, studies of 
childhood maltreatment revealed higher levels of Anger and Physical Aggression in these 
adolescents and as a consequence of that, drug use (Haight et al., 2010).  
 
MA dependence and aggressive behaviour are without a doubt interdependent. An impulsive 
or more aggressive personality style or an environment, which evokes aggressive behaviour 
and gives easy access to the drug, are contributing factors for initiating MA use. Especially in 




drug market is thriving, individuals with drug abuse are more likely to be drawn into 
dangerous situations and therefore behave aggressive. Drug-related aggression may further 
be caused by dealing with gangs independent or related to the dealer, getting money for the 
drugs by stealing or prostitution, or fighting over the drug itself. A study conducted by Cohen 
et al. (2003) showed that 80% of women reported violence or abuse from their partners who 
were using MA.  Cohen et al. concluded that interpersonal violence is part of the “lifestyle” 
of the MA abusing cohort they were studying.  
 
Additionally, the acute psychomotor effects of the drug like sleep deprivation, agitation, 
paranoia and physical activation may further diminish MA user’s ability to make planned and 
thoughtful decisions and therefor lead to situations where they react impulsive and 
aggressive.  
 
On the other hand, animal studies have indicated that MA has a direct effect on behaviour. 
Studies showed increased aggressive behaviour in mice after chronic administration of MA 
(Crowley et al., 1972; Sokolov, Schindler & Cadet, 2004). Of course, findings in animal studies 
cannot always be directly extrapolated to humans. However, Murray et al. (2008) found a 
direct relationship between frequency of drug use and frequency of aggressive behaviour in 
individuals with substance dependence. In addition, Sommers, Baskin & Baskin-Sommers 
(2006) found that half of all individuals with MA abuse who showed aggressive behaviour 
had not committed an aggressive act prior to using MA, supporting the theory that MA 
directly causes aggression. Ultimately, longitudinal studies are needed to assess fully the 
causal relationships between substance use and aggressive behaviour. 
 
Relationship between WM alterations and aggression  
Although other studies have linked impaired WM integrity in frontal regions to aggressive 
behaviour (Hoptman et al., 2002; Ruesch et al., 2007; Peper et al., 2014; Saxena et al., 2012), 
correlational analysis between DTI measures and aggression scores showed no statistical 
significance in this study.  
 
However, in line with our findings, Tobias et al. (2010) could not find a significant correlation 
between FA values in the superior corona radiata in MA dependence and hostility. The 
corona radiata contains, amongst others, reciprocal connections of the cortex and the limbic 




involved PFC and the reward related limbic structures might play a role in the deficits in 
response inhibition and impulsive behaviour seen in MA abuse. Jacobus et al. (2013) showed 
that poorer WM integrity in the superior corona radiata predicted risky behaviour like 
substance abuse in a longitudinal study with adolescents compared to controls. Furthermore, 
Zhang et al. (2014) found a relationship between FA in the superior corona radiata and higher 
impulsivity levels in adolescents with conduct disorder using DTI.  
 
Diverse findings exist for the genu of the CC and its relationship with aggression. Previous 
studies found an association between altered CC structure and aggressive or violent 
behaviour (Hoffman & Schutter, 2009; Raine et al., 1997; Zhang et al., 2014). Nevertheless, a 
DTI study by Saxena at al. (2012) only found trend significance in the correlation between 
aggression and FA in the genu of the CC in a study group of adolescents with bipolar disorder. 
Raine et al. (1997) argues that impaired CC function might not be the main structure 
underpinning aggressive behaviour but may contribute to limbic and cortical dysfunctions. 
 
The CgH, which showed WM abnormalities in the MA group, plays a well-documented role 
in emotion regulation. Kim et al. (2011) showed in an fMRI study hyperactivation of the 
posterior cingulum and parahippocampal gyrus in an emotion-matching task in a group of 
individuals with MA abuse compared to controls. They outline the association of these 
regions with episodic memory. Since MA abuse is associated with more interpersonal 
violence, fearful faces may trigger emotional memories in MA users. Kim et al. argued that 
altered interpersonal communication due to misinterpreted facial expression as social clues, 
could lead to aggressive or hostile behaviour in MA abuse.  In this regard, Payer et al. (2011) 
similarly showed that individuals with MA dependence demonstrate impaired interpretation 
of social clues in another facial affect matching task in an fMRI study. Although they showed 
hyperactivity in the anterior cingulum and not in the posterior, it is interesting to note that 
these changes were accompanied by high self-ratings of hostility.  
 
This study showed several impaired WM structures in individuals with MA dependence. 
Aggressive behaviour is a complex phenomenon and is likely to be regulated by a network of 
underlying brain centres. Therefore, aggression likely cannot be reduced to processes 
occurring in one single brain area. More likely, altered functional connectivity of emotion 
regulating centres may play a role in the reduced inhibitory control, impulsivity, and 




2001; Grafman et al., 1996). Our findings include WM alterations in connections of the PFC 
and limbic regions. The PFC executes complex cognitive control, which implicates control 
over behaviour and decision-making (Coutlee & Huettel, 2012; Heatherton & Wagner, 2011; 
Ridderinkhof et al., 2004). In their review of PFC control and function, Coutlee and Huettel 
(2012), emphasize the importance of the PFC for “self-control”, more specifically in 
“response inhibition, delay of gratification, and thought suppression”, important factors in 
aggressive behaviour as well as in drug abuse. In contrast, the subcortical limbic structures 
are involved in impulsive, affective and reward orientated behaviour (Morgane, Galler & 
Mokler, 2005). Thus, loss of regulatory control of the PFC over limbic structures may be a 
possible explanation for the disinhibited behaviour reported in MA dependence.  
 
The general aggression model has two presumptions. An individual needs emotional insight 
and cognitive control to react towards its environment in a thoughtful manner (Anderson & 
Bushman, 2002). As shown in previous studies, executive function in individuals with MA 
dependence can be impaired (Chung et al., 2007; Kim et al., 2009; Salo et al., 2009). In 
addition, Payer et al. (2011) showed that individuals with MA dependence have poorer 
emotional insight than controls correlating with higher aggression scores. MA users tend to 
have diminished emotional insight as well as reduced cognitive capacity, which makes it 
difficult for them to respond appropriate in situations, which might be dangerous and might 
provoke aggressive behaviour.    
 
Lastly, since we did not find a significant correlation between WM differences and 




The present study has a number of limitations. First, the measure for aggression levels used 
in this study is a self-report questionnaire.  Although other studies have shown that the self-
report measures in substance dependent participants tend to be valid (Darke, 1998), it is not 
clear that in our study the questions were answered without bias. This might either be due 
to participants answering questions as they think it is social desirable (Becker, 2007) or simply 





The second limitation is the different times of MA abstinence, duration of MA use, quantity 
of MA use and age of substance abuse onset in our study cohort. These differences have 
been shown to influence WM integrity and therefore DTI measures. Quantity of MA use in 
particular is difficult to assess because the participants themselves often do not know the 
exact amounts of MA taken over time. Additionally, MA, which is bought on the street from 
different dealers, often is diluted with other substances. Different times of drug abstinence 
have a large influence on WM integrity as shown by Bell et al. (2011). The authors found that 
with prolonged abstinence from cocaine WM integrity in some brain regions improved.  
 
The third limitation lies within the DTI analysis itself. In case of very small WM pathways, 
meaning when a fibre is smaller than a voxel itself, it is difficult to determine whether a 
change in FA is due to WM integrity loss or if the voxel contains other brain tissue, which 
would alter the results (Smith et al., 2006). However, our ROI results in the CC and cingulum 
are likely due to an existent reduction in WM integrity because they are major WM tracts. 
Additionally, the TBSS results in the right superior corona radiata showed a relatively big 
cluster, so that mixed tissue effects would be unlikely. Furthermore, we used thresholding at 
0.2 to avoid exactly this effect. Another limitation of DTI is areas of crossing fibres. As 
discussed above, in these areas measures like FA have to be interpreted carefully. Increase 
or decrease of FA can be due to an altered fibre orientation but does not have to include 
fibre damage.  
 
The fourth limitation is the cross sectional design of our study. Changes in WM integrity could 
already be pre-existing and not a result of the MA use. Ersche et al. (2013) found brain 
changes in healthy individuals, which they shared with their cocaine dependent siblings. They 
found increased impulsivity and compulsivity in both groups and increased volume in striatal-
limbic structures.  
 
Fifth, we found significant differences in levels of education, methaqualone and tobacco use 
in our two groups. These are confounding factors, which all seem to have an influence on 
brain structure and function. Acute and chronic tobacco use has been shown to influence 
WM integrity (Kochunun et al., 2013; Savjani et al., 2014). Additionally, Dunst et al. (2014) 
showed that levels of the Intelligence Quotient (IQ) correlate positively with WM integrity in 
men but not in women. To my best knowledge, there are no DTI studies in methaqualone 




methaqualone are commonly used together - MA in the mornings and methaqualone in the 
evening to induce sleep. Therefore, recruitment of individuals with MA dependence without 
use of methaqualone proved to be almost impossible. We tried to limit the confounding 
factor by excluding methaqualone dependence. 
  
Sixth, the sample size in this study is rather small. This might have the effect that lack of 
findings might be a false negative result. Power calculation was done beforehand but 
estimations for effect size were higher than the results show. Therefore, more participants 
should have been included.  
 
Finally, we used very stringent inclusion and exclusion criteria; therefore, our cohort might 
not represent the majority of individuals with MA dependence. We excluded for example any 
history or current depressive episodes which occur frequently especially in recently abstinent 
MA users.  
 
Relevance  
This study is relevant for the individual MA user, the communities, which struggle with 
violence and the illicit drug markets, and the state that is paying for law enforcement and 
other consequences of illegal drug use.  
 
Aggressive individuals with substance dependence are more likely to have more severe 
dependence symptoms then there non-aggressive counter parts (Bye, 2007; Chermack, Fuller 
& Blow, 2000).They also seem to have more comorbidities due to drug use and more injuries 
(Macdonald et al., 2003; Murray et al., 2008). Moreover, aggression levels seem to influence 
treatment outcome of individuals with drug abuse considerable (Larimer, Palmer & Marlatt, 
1999; Schneider & Timko, 2009; Walton, Chermack & Blow, 2002). Anger in particular is 
linked to high rates of relapse rates, as drug abuse can be a coping strategy for emotional 
conflicts (Klee & Reid, 1998). Therefore, individuals with substance abuse who also show 
elevated aggression levels should be referred for intensified treatment concentrating on 
behavioural coping strategies. 
 
Restoring WM integrity could be a target in substance dependence treatment. It is found that 
that treatment outcome is associated with WM integrity in cocaine dependence and 




have suggested that WM integrity could be partly restored by targeted treatment (Franco et 
al., 2008; Harsan et al., 2008; Schlaug, Martina & Norton, 2010). A possible mechanism to 
restore WM integrity could be achieved through cognitive remediation.  
The so-called cognitive enhancement or remediation is a process of repeated stimulation of 
targeted cognitive functions to improve cognitive performances (Robertson & Murre, 1999). 
This can be achieved by computer-based programs, pharmacological, synchronised 
movements, physical therapy - or any form of repetitive exercise depending on the specific 
pathway to be strengthened. Positive results of computer-based cognitive rehabilitation 
were shown in other psychiatric disorders like schizophrenia or depression (Elgamal et al., 
2007; Penadés et al., 2013). Furthermore, Penadés et al. (2013) showed increased WM 
integrity in schizophrenic patients who underwent cognitive training correlating with 
cognitive improvement compared to healthy controls.  
As discussed above MA dependence can lead to cognitive impairments, which can complicate 
treatment. Patients in therapy need their cognitive ability and flexibility to process and adapt 
newly learned behavioural and psychological strategies. Therefore, computer-based 
rehabilitation programs which concentrate on improving cognitive impairments seen in MA 
dependence like attentional set-shifting, perseveration, action inhibition, impulsivity and 
decision making could help patients in treatment (Vocci, 2008).  
Strengthening WM pathways between the PFC and subcortical limbic structures might help 
gaining self-control over impulsive and immediate reward orientated behaviour and thus 
result in better treatment outcome. 
 
Future research  
Resulting from the limitations of this study, future research should concentrate on 
standardizing drug measurements. A possibility would be splitting the group into subgroups 
of different age started/ duration/ quantity of drug use/ abstinence times and then 
correlating the findings. A costly alternative would be doing hair sample analysis to verify 
drug use statements.  
 
Investigating the different effects of MA on gender would be interesting since previous 
research found a protective effect of oestrogen on neural cells in animal studies (Culmsee et 
al., 1999; Dluzen, 2000). Furthermore, oestrogen was found to protect female mice against 
the neurotoxic effects of MA (Dluzen & McDermott, 2002; Liu & Dluzen, 2006; Myers, 




between increased testosterone levels in adolescents and decreased WM integrity in the 
fronto-temporal-subcortical network. This shows that sex steroids might influence WM 
integrity and vulnerability in gender.  
 
In addition to using the Buss & Perry Questionnaire, future researchers should try to 
implement supplementary measurements of aggressive behaviour.  These could be for 
example: conducting interviews with parents, partners or friends and neuropsychological 
testing. These reports could furthermore help with identifying a cause-effect relationship – 
stating if the participant showed aggressive behaviour even before the drug use or if the 
behaviour changed.  
 
For acquiring cause-effect answers though, a longitudinal study would be essential. This 
could determine if WM changes result from MA use or if WM impairment could also lead to 






















This study provides evidence of WM differences between abstinent individuals with MA 
dependence and healthy controls. Moreover, higher aggression levels in the MA group were 
found. However, there was no significant association between WM changes and aggressive 
behaviour scores, perhaps reflecting a number of limitations in this study. This may also 
indicate that the neurobiology of aggression is not simply correlated with WM damage but is 
more complex. The non-significant correlation could suggest that additional factors other 
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1. Some of my friends think I am a hothead. 1 2 3 4 5 
2. If I have to resort to violence to protect my rights, I 
will. 
1 2 3 4 5 
3. When people are especially nice to me, I wonder 
what they want. 
1 2 3 4 5 
4. I tell my friends openly when I disagree with them. 1 2 3 4 5 
5. I have become so mad that I have broken things. 1 2 3 4 5 
6. I can’t help getting into arguments when people 
disagree with me. 
1 2 3 4 5 
7. I wonder why sometimes I feel so bitter about 
things. 
1 2 3 4 5 
8. Once in a while, I can’t control the urge to strike 
another person. 
1 2 3 4 5 
9. I am an even-tempered person. 1 2 3 4 5 
10. I am suspicious of overly friendly strangers. 1 2 3 4 5 
11. I have threatened people I know. 1 2 3 4 5 
12. I flare up quickly but get over it quickly. 1 2 3 4 5 
13. Given enough provocation, I may hit another 
person. 
1 2 3 4 5 
14. When people annoy me, I may tell them what I 
think of them. 
1 2 3 4 5 
Instructions: Using the 5 point scale shown below, indicate how uncharacteristic or 
characteristic each of the following statements is in describing you. To place your rating 
for each question, circle the number that best describes how you feel. 
 
1 = extremely uncharacteristic of me 
2 = somewhat uncharacteristic of me 
3 = neither uncharacteristic nor characteristic of me 
4 = somewhat characteristic of me 


















































































15. I am sometimes eaten up with jealousy. 1 2 3 4 5 
16. I can think of no good reason for ever hitting a 
person. 
1 2 3 4 5 
17. At times I feel I have gotten a raw deal out of life. 1 2 3 4 5 
18. I have trouble controlling my temper. 1 2 3 4 5 
19. When frustrated, I let my irritation show. 1 2 3 4 5 
20. I sometimes feel that people are laughing at me 
behind my back. 
1 2 3 4 5 
21. I often find myself disagreeing with people. 1 2 3 4 5 
22. If somebody hits me, I hit back. 1 2 3 4 5 
23. I sometimes feel like a powder keg ready to 
explode. 
1 2 3 4 5 
24. Other people always seem to get the breaks. 1 2 3 4 5 
25. There are people who pushed me so far that we 
came to blows. 
1 2 3 4 5 
26. I know that “friends” talk about me behind my 
back. 
1 2 3 4 5 
27. My friends say that I’m somewhat argumentative. 1 2 3 4 5 
28. Sometimes I fly off the handle for no good 
reason. 
1 2 3 4 5 
29. I get into fights a little more than the average 
person. 













PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT:  
Neural correlates of deficits in affect regulation in methamphetamine abusers with a history of 
psychosis  
  
REFERENCE NUMBER: 340/2009  
 
 
PRINCIPAL INVESTIGATOR: Dr Donald Wilson 
 
ADDRESS: University of Cape Town, Dept of Psychiatry and Mental Health, Groote Schuur 
Hospital (J2), Anzio Road, Observatory 7925, Cape Town, South Africa 
 






You are being invited to take part in a research project. Please take some time to read 
the information presented here, which will explain the details of this project. Please 
ask the study staff or doctor any questions about any part of this project that you do 
not fully understand. It is very important that you are fully satisfied that you clearly 
understand what this research entails and how you could be involved. Also, your 
participation is entirely voluntary and you are free to decline to participate. If you say 
no, this will not affect you negatively in any way whatsoever. You are also free to 
withdraw from the study at any point, even if you do agree to take part.  
 
This study has been approved by the Faculty of Health Sciences Human Research 
Ethics Committee (FHS HREC) of the University of Cape Town, and will be conducted 
according to the ethical guidelines and principles of the international Declaration of 
Helsinki, South African Guidelines for Good Clinical Practice and the Medical 
Research Council (MRC) Ethical Guidelines for Research. 
 
This project is being run at the Department of Psychiatry, University of Cape Town. 
We aim to recruit a total of 60 participants over a period of 3 years. 
 
What is this research study all about?  
Background: The increasing use of methamphetamine (MA, also “tik” or “meth”) is a 
cause for concern for a number of reasons. On the personal level the chronic use of 
MA has been associated with brain damages resulting in potentially long-lasting 
mental health effects including confusion, impaired concentration and memory. 
Imaging studies have shown that MA use is associated with imbalances in the 
neurochemistry of the brain. Thus long-term abuse of “tik” or “meth” is associated with 
the development of paranoid, often violent psychotic states accompanied by auditory, 
visual and/or tactile hallucinations. MA abuse also has profound consequences on an 
interpersonal level, due to associated impairments in emotion regulation. For 
instance, aggression and hostility have been consistently identified in chronic users 
of MA and such emotional disturbances have been associated with abnormalities in 





Methods: Participants will have to complete questionnaires and a series of 
behavioural tasks used to determine whether MA abuse and MA-induced psychosis 
is associated with defects in social awareness and regulation of emotions. In addition, 
brain imaging techniques will be used to determine the effect of MA abuse, with and 
without a history of psychosis, on brain structure and function. Specifically, structural 
magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS) and 
diffusion tensor imaging (DTI) will be employed to investigate how brain structure and 
metabolism change in MA abusers in comparison to healthy controls. DNA analyses 
of blood samples will be conducted to examine whether specific genes account for 
structural and functional brain abnormalities after methamphetamine abuse and for 
increased vulnerability to psychosis. 
In addition, associations between “tik” abuse and the disability of controlling emotions 
will be assessed. Participants will therefore perform a simple task (Affective Labelling 
task) measuring emotional processing as part of the functional MRI scan. This task 
will be used to assess differences in brain activation corresponding to impairments in 




If you agree to take part in the study and if you meet all of the conditions required for 
entering the study (assessed in a screening interview), you will complete the following 
3 phases and procedures: 
 At your first visit the study will be explained and written consent to take part will 
be obtained. Your study investigator will ask you some questions about your 
psychiatric and neurological history and you will have to fill out several 
questionnaires. If you are eligible and agree to participate in the study you will be 
asked to attend the second testing session at the Cape Universities Brain Imaging 
Centre (www.sun.ac.za/cubic). 
 During the second testing day, you will be asked to complete behavioural tasks. 
Following completion of these tasks the brain scanning session, Magnetic 
Resonance Imaging (MRI) and Spectroscopy (MRS), will take place. 
 During the third visit you will undergo neuropsychological testing including tasks 
about your memory, attention and risk taking behaviour. 
It is estimated that none of the testing sessions should take more than 3 hours to 
complete. 
 
The psychiatric interview will take place either at Valkenberg Hospital or in the 
Psychiatric department at Groote Schuur Hospital. Brain imaging will be conducted 
using a 3T Siemens Magnetom Allegra at CUBIC, Stellenbosch. Each scanning 
session will last approximately one hour. Structural and functional imaging data will 
be acquired. Stimuli for each cognitive-affective protocol will be computerized and 
displayed to you in the scanner via a screen display. The neuropsychological 
assessment, which will be computer based tests, will take place in the Psychiatric 
Department of Groote Schuur Hospital.  
 
Urine screens will be performed on both days of testing to verify methamphetamine 
abstinence and to determine the degree of cannabis use, as well as for a pregnancy 
test (if you are female). You will have to pee in a cup for those tests. The results of 
those tests are not for legal medicine or police purpose, and will only be used for our 
study. 
 
Blood samples will be collected for routine laboratory testing and for possible future 
gene and protein expression studies. Approximately 35ml (7 teaspoons) of blood will 




sample should we fail to get a DNA sample from your blood. Candidate 
polymorphisms identified to be associated with drug dependency or psychosis and 
possibly playing a role in explaining variance in the MRI results will be investigated 
later on. This process will take place at the Division of Human Genetics at the 
University of Cape Town. 
 
Magnetic Resonance Imaging 
 
With an MRI you can obtain very detailed images of organs and tissues throughout 
the body, even of the brain, as in our study. MRS provides a tool to investigate 
metabolites in the living brain. Both MRI and MRS testing cause no pain and the 
magnetic fields produce no known tissue damage of any kind.  
 
The MRI and MRS examination are performed in a special room that houses the MR 
system or "scanner". You will be escorted into the room by a staff member of the MRI 
facility and asked to lie down on a comfortably padded table that gently glides you into 
the scanner. This is typically a large, tunnel magnet that is open at both ends, so you 
won't be completely enclosed at any time.  
 
As the scan is done in a relatively confined space, occasionally people feel closed-in 
or frightened. This does not happen often, and if you feel anxious, we will spend time 
allowing you to get used to the surroundings. Another side-effect might be a tingling 
feeling in your teeth if you have metal fillings. 
 
The most important thing for you to do is to relax and lie perfectly still during the 
time the imaging takes place. For the functional imaging you will be asked to perform 
some simple tasks of emotional processing and attention, which will enable the 
investigators to determine your brain function. During the structural and diffusion 
tensor imaging you will be able to close your eyes and rest. Given that the testing 
session will take one hour to complete, you might get sleepy or uncomfortable after a 
while, but you are asked to stay awake and not to move throughout the scanning.  
 
A radiologist will operate the scanner from behind a window, and will be able to see 
and hear you during the scan. You will be able to communicate with the radiologist or 
the study assistant at any time using an intercom system. You will also be given an 
alarm call button to hold during the scan, which you can press to get attention. 
 
The MR scanner may produce loud tapping or knocking noises at times during the 
testing, which is normal and should not worry you. Especially when the magnet in the 
machine is switched on, it will make some loud banging noises, but you will be clearly 
warned when this will take place. You will feel nothing and the noise is not harmful to 
you in any way. To minimise the possible discomfort associated with this, we will give 
you some soft earplugs to put in. 
 
MRI and MRS scans are commonly performed and a safe procedure if you have been 
screened correctly for the presence of any magnetic material on or inside you such 
as pace-makers, surgical clips and metal objects in the eyes. A formal screen for this 
will be done at the screening visit by a member of the study team. 
 
Why have you been invited to participate? 
Three groups of participants will be included in this study: methamphetamine (MA) 
abusers with a history of psychosis, MA abusers without a history of psychosis and 




20 participants. You may fit into one of these categories as assessed during your 
initial screening. 
 
What will your responsibilities be? 
 
The study investigator will be required to ask you about medications that you may be 
taking currently or that you may have taken recently. Your study investigator will 
explain to you which medications need to be stopped during the entire length of the 
study and how soon before you take part in the study these medications must be 
stopped. 
 
Your doctor will also advise you on which prescription or over-the-counter medications 
or any other remedies or foods that you will be required to either stop or restrict your 
consumption of during the entire length of the study. This will include a restriction on 
the amount of alcohol that can be consumed. 
 
At each visit you may be asked to complete questionnaires or tasks to check the 
status of your symptoms. These will measure your mood, emotional responses, trust, 
sociability and emotional resilience. 
 
Please ensure that you are punctual at all times, as we are using specialized 
equipment during each of the sessions, for which costs are incurred. If for some 
reason you are unable to complete a visit on a particular day we may reschedule to 
complete the assessments at another time.  
 
Will you benefit from taking part in this research? 
 
There are no direct benefits to you for participating in this study. However, you will be 
making an important contribution to this research that may benefit others in the future. 
We expect that the results of this study will help us understand the effects of 
methamphetamine on brain structure and function and how their abuse can lead to 
the development of psychosis. 
 
Are there any risks involved in your taking part in this research? 
 
There are no major risks involved in participation in this study. There will be several 
questionnaires, including some about past traumatic events that ask for information 
of a very personal and sensitive nature. This may cause some emotional discomfort. 
 
Who will have access to your medical records? 
 
Maintaining your confidentiality is important. Your personal information (for example 
your gender, age, the details of your medical conditions) and other information (the 
data collected by the investigators as part of the study) will be identified by a number 
(i.e. coded). Your name will not appear in any publications or reports produced from 
this study. The investigators will keep the information and the results collected about 





By agreeing to take part in this study, you will be allowing certain persons to see the 
information about you (both personal, including your name, and other information) 
held by the study doctor. You have the right to withdraw your consent to participate in 
this study at any time. 
 
If you withdraw your consent to participate in this study no new information will be 
collected from you and added to existing data or to a database. Your information will 
be processed electronically (i.e. by a computer) or manually and analysed to 
determine the outcome of this study. Your information may/could be sent to regulatory 
authorities and to the Ethics Committees. You have the right to ask the study doctor 
about the data being collected on you for the study and about the purpose of this data. 
You have the right to ask the study doctor to allow you to see your personal 
information and to have any necessary corrections made to it. 
What will happen in the unlikely event of some form of injury occurring as a 
direct result of your taking part in this research study? 
 
If you become ill or injured as a direct result of your participation in this clinical study, 
you will be referred for appropriate medical treatment. The University of Cape Town’s 
insurance policy will cover the costs of such treatment. If you have any questions 
concerning the availability of compensation/medical care or if you think you have 
experienced a research-related illness or injury, contact details are below. Your legal 
right to claim compensation for injury where you can prove negligence is not affected.  
 
If you have any questions about your rights as a research subject, you should contact 
the Faculty of Health Sciences Human Research Ethics Committee (FHS HREC), Tel: 
(021)4066492, Fax: (021)4066411. 
 
If you have questions about this study you should first discuss them with your study 
doctor or the Faculty of Health Sciences Human Research Ethics Committee (FHS 
HREC), UCT.  
Dr D. Wilson:  (021)4042182 
Dr H. Temmingh:  (021)4403185 
After you have consulted your doctor or the FHS HREC and if they have not provided 
you with answers to your satisfaction, you should write to the South African Medical 
Research Council at: Head Office Cape Town, Corporate Communications Office, 
Sarah Bok,  PO Box 19070, Tygerberg, 7505, South Africa or Fax: (021)9380200. 
 
Will you be paid to take part in this study and are there any costs involved? 
 
All evaluations will be provided, hence there will be no costs involved for you or your 
medical aid, if you do take part in the study. You will be compensated for taking part 
in the study as your transport and meal costs will be covered with supermarket 
vouchers to exchange for food, amounting to R150.  
 
Is there any thing else that you should know or do? 
 You can contact the Committee for Human Research at (021)4066492 if you have 
any concerns or complaints that have not been adequately addressed by your 
study doctor. 






Informed Consent Form for Study Participants 
Title of the Research Project: “Neural correlates of deficits in affect regulation in 





Declaration by participant 
 
1. By signing below, I …………………………………..…………. agree to be 
interviewed and asked personal information as part of the above named study and 
that the information I give will be correct. Furthermore, I declare that: 
 I have read, or had read to me, the “Participant Information Leaflet and Consent 
Form” and it is written in a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced 
in any way. 
 I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
Signed at (place) ......................…........…………….. on (date) …………....…. 20     . 
 
 ...............................................................   
Signature of participant 
  
 
2. By signing below, I …………………………………..…………. agree to have my 
blood taken for the proposed genetic tests as described in the “Participant 
Information Leaflet and Consent Form”. 
 
Signed at (place) ......................…........…………….. on (date) ……….…….. 20     . 
 
 ...............................................................   
Signature of participant  
 
3. By signing below, I …………………………………..…………. agree to undergo 
brain scans (MRI/MRS) as described in the “Participant Information Leaflet and 
Consent Form”. 
 
Signed at (place) ......................…........…………….. on (date) …………….. 20     . 
 
 ...............................................................   





4. By signing below, I …………………………………..…………. agree to 
Neuropsychological testing as described in the “Participant Information Leaflet and 
Consent Form”. 
 
Signed at (place) ......................…........…………….. on (date) ……...……….. 20     . 
 
 ...............................................................   
Signature of participant  
 
 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 20     
. 
 
 ...................................................................   
Signature of investigator  
 
